<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Biol Chem</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39706268</article-id><article-id pub-id-type="pmc">PMC11786768</article-id><article-id pub-id-type="pii">S0021-9258(24)02596-1</article-id><article-id pub-id-type="doi">10.1016/j.jbc.2024.108094</article-id><article-id pub-id-type="publisher-id">108094</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Menaquinone-specific turnover by <italic>Mycobacterium tuberculosis</italic> cytochrome <italic>bd</italic> is redox regulated by the Q-loop disulfide bond</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>van der Velden</surname><given-names>Tijn T.</given-names></name></contrib><contrib contrib-type="author" id="au2"><name><surname>Kayastha</surname><given-names>Kanwal</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Waterham</surname><given-names>Caspar Y.J.</given-names></name></contrib><contrib contrib-type="author" id="au4"><name><surname>Br&#x000fc;nle</surname><given-names>Steffen</given-names></name></contrib><contrib contrib-type="author" id="au5"><name><surname>Jeuken</surname><given-names>Lars J.C.</given-names></name><email>L.J.C.Jeuken@lic.leidenuniv.nl</email><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1">Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>For correspondence: Lars J. C. Jeuken <email>L.J.C.Jeuken@lic.leidenuniv.nl</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>18</day><month>12</month><year>2024</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2024</year></pub-date><volume>301</volume><issue>2</issue><elocation-id>108094</elocation-id><history><date date-type="received"><day>9</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>2</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 The Authors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>Cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic> (<italic>Mtbd</italic>) is a menaquinol oxidase that has gained interest as an antibiotic target because of its importance in survival under infectious conditions. <italic>Mtbd</italic> contains a characteristic disulfide bond that has been hypothesized to allow for <italic>Mtbd</italic> activity regulation at the enzymatic level, possibly helping <italic>M.&#x000a0;tuberculosis</italic> to rapidly adapt to the hostile environment of the phagosome. Here, the role of the disulfide bond and quinone specificity have been determined by reconstitution of a minimal respiratory chain and the single-particle cryo-EM structure in the disulfide-reduced form. <italic>Mtbd</italic> was shown to be specific for menaquinone, while regulation by reduction of the Q-loop disulfide bond decreased oxidase activity up to 90%. Structural analysis shows that a salt bridge unique to <italic>Mtbd</italic> keeps the Q-loop partially structured in its disulfide-reduced form, which could facilitate the rapid activation of <italic>Mtbd</italic> upon exposure to reactive oxygen species. We signify <italic>Mtbd</italic> as the first redox sensory terminal oxidase and propose that this helps <italic>M.&#x000a0;tuberculosis</italic> in the defense against reactive oxygen species encountered during infection.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>ubiquinone</kwd><kwd>demethylmenaquinone</kwd><kwd>cryo-EM</kwd><kwd>respiration</kwd><kwd>substrate specificity</kwd><kwd>disulfide regulation</kwd></kwd-group></article-meta><def-list><title>Abbreviations</title><def-item><term id="kwrd0045">CTF</term><def><p>contrast transfer function</p></def></def-item><def-item><term id="kwrd0055">Cyt <italic>bd</italic></term><def><p>cytochrome <italic>bd</italic></p></def></def-item><def-item><term id="kwrd0065">DDM</term><def><p>dodecyl beta-d-maltoside</p></def></def-item><def-item><term id="kwrd0075">DMK</term><def><p>demethylmenaquinone</p></def></def-item><def-item><term id="kwrd0085">Ecbd</term><def><p>cytochrome bd from Escherichia coli</p></def></def-item><def-item><term id="kwrd0095">LMNG</term><def><p>lauryl maltose neopentyl glycol</p></def></def-item><def-item><term id="kwrd0105">2-ME</term><def><p>2-mercaptoethanol</p></def></def-item><def-item><term id="kwrd0115">MK</term><def><p>menaquinone</p></def></def-item><def-item><term id="kwrd0125">Mtbd</term><def><p>cytochrome bd from Mycobacterium tuberculosis</p></def></def-item><def-item><term id="kwrd0135">PDB</term><def><p>Protein Data Bank</p></def></def-item><def-item><term id="kwrd0145">PE</term><def><p>phosphatidylethanolamine</p></def></def-item><def-item><term id="kwrd0155">ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term id="kwrd0165">SEC</term><def><p>size-exclusion chromatography</p></def></def-item><def-item><term id="kwrd0175">TCEP</term><def><p>Tris(2-carboxyethyl)phosphine</p></def></def-item><def-item><term id="kwrd0185">UQ</term><def><p>ubiquinone</p></def></def-item></def-list><notes><p id="misc0010">Reviewed by members of the JBC Editorial Board. Edited by Chris Whitfield</p></notes></front><body><p id="p0010">Cytochrome <italic>bd</italic> (cyt <italic>bd</italic>) is a terminal oxidase found in the respiratory chain across various bacterial phyla and couples the oxidation of quinols to the reduction of molecular oxygen to water (<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>). The chemical protons released by quinol oxidation are separated from the proton uptake for oxygen reduction by the cytoplasmic membrane, generating a proton motive force required for ATP synthesis (<xref rid="bib3" ref-type="bibr">3</xref>). Compared with other terminal oxidases, cyt <italic>bd</italic> is distinguished by its resistance to inhibitors, such as cyanide, high affinity for oxygen, and upregulation under microaerobic conditions (<xref rid="bib4" ref-type="bibr">4</xref>).</p><p id="p0015">Recent findings highlight the significance of cyt <italic>bd</italic> as a key survival factor for <italic>Mycobacterium tuberculosis</italic> during infection, particularly in the hostile granulomas where the bacteria reside (<xref rid="bib5" ref-type="bibr">5</xref>). Only upon inhibition of both terminal oxidases, cyt <italic>bcc:aa</italic><sub><italic>3</italic></sub> and cyt <italic>bd</italic>, bactericidal effects are observed (<xref rid="bib6" ref-type="bibr">6</xref>). When <italic>M.&#x000a0;tuberculosis</italic> cyt <italic>bcc</italic>:<italic>aa</italic><sub>3</sub> is inhibited and cyt <italic>bd</italic> from <italic>M.&#x000a0;tuberculosis</italic> (<italic>Mtbd</italic>) functions as the sole terminal oxidase, it can maintain a bacteriostatic state (<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib6" ref-type="bibr">6</xref>) and enhances resistance against numerous antibiotics, reactive oxygen species (ROS), and other toxic compounds (<xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>). This pivotal role during infection has identified <italic>Mtbd</italic> as a potential antibiotic target.</p><p id="p0020">Despite this therapeutic potential, most of our current understanding of <italic>Mtbd</italic> at the molecular level is obtained from studies performed on homologous enzymes, such as <italic>Corynebacterium glutamicum</italic> cyt <italic>bd</italic> and the two <italic>Escherichia coli</italic> cyt <italic>bd</italic> isoforms, cyt <italic>bd</italic>-I (<italic>Ecbd</italic>) and cyt <italic>bd</italic>-II. Since these enzymes have been shown to have distinct structural features, number of subunits, and substrate-binding pockets (<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>), caution is required when associating prior knowledge to <italic>Mtbd</italic>. An important characteristic feature of <italic>Mtbd</italic> is a disulfide bond constraining the N-terminal Q-loop domain near the quinone-binding pocket (<xref rid="bib14" ref-type="bibr">14</xref>). It has been hypothesized that this disulfide bond provides a regulatory switch (<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib19" ref-type="bibr">19</xref>) and allows <italic>M.&#x000a0;tuberculosis</italic> to instantly adapt to inhibition of its electron transport chain by rerouting electrons to <italic>Mtbd</italic>, suggesting regulation at the enzyme level in response to hostile conditions (<xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>). Redox-sensing disulfide bonds have been found in other proteins, such as transcription factors, signaling enzymes, CO<sub>2</sub> reductases, and peroxidases as a defense against oxidative stress (<xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib23" ref-type="bibr">23</xref>). However, whether such a regulatory function is conferred by the <italic>Mtbd</italic> Q-loop remains speculative, because its study has been hampered by the need for chemical reductants to reduce the quinone substrates in the standard activity assays for cyt <italic>bd</italic> oxidase. Given its significance as a potential antibiotic target, it is essential to uncover the main features of <italic>Mtbd</italic> enzyme kinetics.</p><p id="p0025"><italic>Ecbd</italic>, <italic>Mtbd</italic>, and cyt <italic>bd</italic>s from other species use distinct quinone subtypes for turnover. The main bacterial quinone subtypes include menaquinone (MK), demethylmenaquinone (DMK), and ubiquinone (UQ), each differing in their quinone headgroup structure and corresponding redox potential (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref><italic>A</italic>) (<xref rid="bib24" ref-type="bibr">24</xref>). In addition, these quinones contain a hydrophobic isoprenoid tail made from a distinct number of isoprene units (<xref rid="bib25" ref-type="bibr">25</xref>). By convention, the number of isoprene units is indicated by the number (n) after the quinone, for example, MK-n. <italic>M.&#x000a0;tuberculosis</italic> primarily relies on MK-9 (<xref rid="bib26" ref-type="bibr">26</xref>), whereas <italic>E.&#x000a0;coli</italic> demonstrates distinct functionalities for MK-8, DMK-8, and UQ-8 (<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>). Moreover, <italic>E.&#x000a0;coli</italic> upregulates MK-8 during microaerobic conditions, coinciding with the upregulation of <italic>Ecbd</italic>, highlighting the adaptability of the <italic>E.&#x000a0;coli</italic> quinone pool composition based on environmental requirements (<xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib29" ref-type="bibr">29</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p><bold>Overview of quinone subtypes and structural features of <italic>Mtbd.</italic></bold><italic>A</italic>, the structure of quinone analogs used in this study with the number of isoprenoid units (n) and their reduction potentials (<xref rid="bib24" ref-type="bibr">24</xref>). <italic>B</italic>, oxidized structure of <italic>Mtbd</italic> (Protein Data Bank code: <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/7NKZ" id="intref0030">7NKZ</ext-link>) (<xref rid="bib14" ref-type="bibr">14</xref>), CydA (<italic>green</italic>), CydB (<italic>red</italic>), indicating the Q-loop disulfide bond and MK-9 (<italic>purple</italic>). <italic>Mtbd</italic>, cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic>.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0030">The interactions between quinones and cyt <italic>bd</italic> are intricate, as demonstrated by the distinct quinone-binding sites in <italic>Ecbd</italic> and <italic>Mtbd</italic> (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S1</xref>). While <italic>Ecbd</italic> has a proposed quinone-binding pocket at the Q-loop of subunit CydA, transferring electrons to closely located heme <italic>b</italic><sub>558</sub> (<xref rid="bib16" ref-type="bibr">16</xref>), <italic>Mtbd</italic> shows quinone binding at the back of CydA, which is hypothesized to transfer electrons directly to heme <italic>b</italic><sub>595</sub>, bypassing the initial heme <italic>b</italic><sub>558</sub> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref><italic>B</italic>) (<xref rid="bib14" ref-type="bibr">14</xref>). Additional structural quinone-binding pockets are found in CydB, lacking participation in quinol oxidation (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib18" ref-type="bibr">18</xref>). The exact position of the <italic>Ecbd</italic> and <italic>Mtbd</italic> turnover sites remains to be determined.</p><p id="p0035">Most studies make use of detergent-solubilized cyt <italic>bd</italic> with water-soluble quinone analogs. The use of detergent micelles, although convenient for studying cyt <italic>bd</italic> in solution, introduces an artificial environment that deviates from the native conditions. These detergent micelles can alter the conformation, partially unfold proteins, and strip away vital bound or annular lipids, leading to a loss of native mechanistic function and kinetic rates (<xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>). In addition, using water-soluble quinone analogs can significantly alter enzyme kinetics as the quinone isoprenoid tail has been shown to critically affect respiratory efficiency in <italic>M.&#x000a0;tuberculosis in&#x000a0;vivo</italic> (<xref rid="bib32" ref-type="bibr">32</xref>). The evaluation of cyt <italic>bd</italic> quinone interactions and disulfide regulation thus requires a native membrane environment and natural quinone substrates to mimic native conditions.</p><p id="p0040">To study the specific interaction of <italic>Ecbd</italic> and <italic>Mtbd</italic> with the different quinones and interrogate the role of the <italic>Mtbd</italic> Q-loop disulfide bond, a minimal respiratory chain was constructed in which cyt <italic>bd</italic> is combined with a NADH&#x02013;quinone oxidoreductase, <italic>Caldalkalibacillus thermarum</italic> NDH-2 (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). This approach was inspired by an approach in which complex 1 was studied using an alternative oxidase (<xref rid="bib33" ref-type="bibr">33</xref>). Enzyme kinetics reveal that water-soluble quinone analogs lead to vast overestimations of cyt <italic>bd</italic> turnover rates, highlighting the need for precise experimental design. Furthermore, in contrast to <italic>Ecbd</italic>, <italic>Mtbd</italic> is subject to substrate inhibition by MK at physiologically relevant concentrations. In addition, we signify <italic>Mtbd</italic> as the first terminal oxidase with a redox sensory disulfide bond. Cryo-EM analysis of the disulfide-reduced <italic>Mtbd</italic> revealed a new interaction between Arg290 and Glu263 that might explain why <italic>Mtbd</italic> is readily reactivated upon reformation of the disulfide bond, for instance by exposure to H<sub>2</sub>O<sub>2</sub>. We propose that redox regulation enables <italic>Mtbd</italic> to quickly adapt its activity to environmental redox pressures in defense against ROS encountered by <italic>M.&#x000a0;tuberculosis</italic> during infection.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p><bold>A minimal respiratory chain proteoliposomal system to interrogate specific interactions between quinones and cyt <italic>bd</italic>.</bold> This proteoliposomal system can also be used in detergent. Cyt <italic>bd</italic>, cytochrome <italic>bd</italic>.</p></caption><graphic xlink:href="gr2"/></fig></p><sec id="sec1"><title>Results</title><sec id="sec1.1"><title>Cyt <italic>bd</italic> oxygen consumption kinetics with water-soluble quinone analogs</title><p id="p0045"><italic>Ecbd</italic>, <italic>Mtbd</italic>, and NDH-2 were expressed and purified <italic>via</italic> affinity and size-exclusion chromatography (SEC; <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S2</xref>). A minimal respiratory chain was constructed with an excess of NADH and NDH-2, such that the quinone pool remains fully reduced. Control studies with varying amounts of NDH2 confirmed that cyt <italic>bd</italic> activity was limiting. The enzyme activity of <italic>Ecbd</italic> and <italic>Mtbd</italic>, comparing different quinone substrates, was determined by monitoring oxygen consumption in a Clark electrode. The activity was first measured in detergent conditions using water-soluble quinone analogs. Previous reports indicate that quinols, especially menaquinols, auto-oxidize under aerobic conditions in a concentration-dependent manner (<xref rid="bib34" ref-type="bibr">34</xref>). To account and correct for the quinol (Q) auto-oxidation rate, the oxygen consumption was quantified for each assay before the addition of cyt <italic>bd</italic> (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref><italic>A</italic>). <italic>Ecbd</italic> displayed standard Michaelis&#x02013;Menten kinetics with a sixfold lower <italic>K</italic><sub>m</sub> for MK-1 compared with UQ-1 (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref><italic>B</italic> and <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). <italic>K</italic><sub>cat</sub> values for the three quinone analogs were similar (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>) ranging from 736 to 1033 Q/s (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><bold>Oxygen consumption kinetics of detergent-solubilized cyt <italic>bd</italic> with different quinone substrates.</bold><italic>A</italic>, example of an oxygen consumption trace with MK-1 (50&#x000a0;&#x003bc;M) auto-oxidation (Auto-ox) and <italic>Ecbd</italic> oxygen consumption indicated. <italic>B</italic>, <italic>Ecbd</italic> and, (<italic>C</italic>) <italic>Mtbd</italic> oxygen consumption kinetics using the assay described in the text at 20 &#x000b0;C. <italic>Lines</italic> represent Michaelis&#x02013;Menten fits without (<italic>Ecbd</italic>, see <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref> for parameter values) or with (<italic>Mtbd</italic>) substrate inhibition. <italic>D</italic>, <italic>Mtbd</italic> activity with 50&#x000a0;&#x003bc;M MK-1 in the absence or presence of either DMK-1 or UQ-1 (both 300&#x000a0;&#x003bc;M). Data are represented as the average and standard deviation of triplicate measurements of two different protein preparations (n&#x000a0;= 3). Significance is tested using an ANOVA with a Dunnett <italic>post hoc</italic> test in GraphPad Prism. &#x02217;&#x02217;<italic>p</italic>&#x000a0;&#x0003c; 0.01. Cyt <italic>bd</italic>, cytochrome <italic>bd</italic>; DMK, demethylmenaquinone; <italic>Ecbd</italic>, cytochrome <italic>bd</italic> from <italic>Escherichia coli</italic>; MK, menaquinone; <italic>Mtbd</italic>, cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic>; UQ-1, ubiquinone&#x000a0;1.</p></caption><graphic xlink:href="gr3"/></fig><table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Kinetic parameters for the oxidation of UQ-1, DMK-1, and MK-1 by <italic>Ecb</italic><italic>d</italic><xref rid="tbl1fna" ref-type="table-fn">a</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"><italic>K</italic><sub>cat</sub> (Q s<sup>&#x02212;1</sup>)<hr/></th><th colspan="3"><italic>K</italic><sub>m</sub> (&#x003bc;M)<hr/></th><th colspan="3"><italic>K</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub> (&#x000d7;10<sup>&#x02212;6</sup>&#x000a0;M<sup>&#x02212;1</sup>&#x000a0;s<sup>&#x02212;1</sup>)<hr/></th></tr><tr><th>UQ-1</th><th>DMK-1</th><th>MK-1</th><th>UQ-1</th><th>DMK-1</th><th>MK-1</th><th>UQ-1</th><th>DMK-1</th><th>MK-1</th></tr></thead><tbody><tr><td>1033&#x000a0;&#x000b1;&#x000a0;85</td><td align="char">736&#x000a0;&#x000b1;&#x000a0;51</td><td align="char">846&#x000a0;&#x000b1;&#x000a0;38</td><td align="char">149&#x000a0;&#x000b1;&#x000a0;26</td><td align="char">44&#x000a0;&#x000b1;&#x000a0;10</td><td align="char">22&#x000a0;&#x000b1;&#x000a0;4</td><td align="char">6.9&#x000a0;&#x000b1;&#x000a0;1.3</td><td align="char">16.7&#x000a0;&#x000b1;&#x000a0;4.0</td><td align="char">38.5&#x000a0;&#x000b1;&#x000a0;7.2</td></tr></tbody></table><table-wrap-foot><fn id="tbl1fna"><label>a</label><p id="ntpara0010">Oxygen consumption measurements were performed in 50 mM Mops, 150 mM NaCl, 0.005% LMNG, pH 7.0 (n = 3). Data represent best Michaelis&#x02013;Menten fit values with the SEM. <italic>K<sub>cat</sub></italic> values are represented in quinones per second (2 e-/Q). <italic>K<sub>cat</sub></italic>: UQ-1 <italic>versus</italic> DMK-1 (p&#x0003c;0.05). <italic>K<sub>m</sub></italic> UQ-1 <italic>versus</italic> DMK-1 (p&#x0003c;0.001), UQ-1 <italic>versus</italic> MK-1 (p &#x0003c; 0.0001), DMK-1 <italic>versus</italic> MK-1 (p &#x0003c; 0.05). <italic>K<sub>cat</sub>/K<sub>m</sub></italic>, errors represent the propagated SEM.</p></fn></table-wrap-foot></table-wrap></p><p id="p0050">The kinetic profile of <italic>Mtbd</italic> was profoundly different than that of <italic>Ecbd</italic> (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref><italic>C</italic>). <italic>Mtbd</italic> exclusively turns over MK-1 and is subject to substrate inhibition. While substrate inhibition has been observed in other oxidases (<xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref>), its molecular mechanism remains undefined. Multivariate fits of the observed substrate inhibition profile indicated a large interdependency of parameters (<italic>K</italic><sub>m</sub>; <italic>V</italic><sub>max</sub>; inhibition constant, <italic>K</italic><sub>i</sub>) preventing the determination of the kinetic parameters for MK-1 oxidation in spite of the good fit (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref><italic>C</italic>). Importantly, <italic>Mtbd</italic> failed to initiate turnover with either DMK-1 or UQ-1. To investigate whether this inactivity resulted from a lack of substrate binding or a thermodynamic barrier limiting quinol oxidation, the effect of UQ-1 and DMK-1 on <italic>Mtbd</italic> activity was assessed. It was reasoned that DMK-1 and UQ-1 will present as competitive inhibitors if they bind to the same active-site pocket as MK-1. Upon addition of an excess DMK-1 or UQ-1, oxygen consumption activity was indeed significantly inhibited, suggesting that DMK-1 and UQ-1 bind to the active site but are unable to be oxidized by <italic>Mtbd</italic> (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref><italic>D</italic>). This inhibitory effect of DMK-1 was shown to be concentration dependent and indicates a lower overall affinity for DMK-1 than MK-1 (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S3</xref>).</p></sec><sec id="sec1.2"><title><italic>Ecbd</italic> and <italic>Mtbd</italic> oxygen consumption in proteoliposomes</title><p id="p0055">To determine whether the observed substrate specificities in detergent are indicative of native conditions, the same principles were applied to a proteoliposomal system (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>) where cyt <italic>bd</italic> can be studied in a native-like lipid environment using the long isoprenoid quinones MK-9 and UQ-10.</p><p id="p0060"><italic>Mtbd</italic> and <italic>Ecbd</italic> were reconstituted in liposomes containing 0.25%&#x02013;1% (molar; quinone/lipid) of the desired quinone (MK-9 or UQ-10) to achieve maximum catalytic rates. The <italic>Mtbd</italic> or <italic>Ecbd</italic> concentration after reconstitution was quantified using the Soret band of a detergent-solubilized sample. Native quinone concentrations in bacterial membranes are estimated between 0.3 and 1.5% (see <xref rid="sec1" ref-type="sec">Supporting information</xref>). Furthermore, 1% MK-9 or UQ-10 approximately coincides with a membrane concentration in the order of 10 to 15&#x000a0;mM (see <xref rid="sec1" ref-type="sec">Supporting information</xref>, well above the <italic>K</italic><sub>m</sub> determined for <italic>Ecbd</italic>. We note however, that for the water-soluble quinone analogs, an unknown equilibrium exists between quinones in solution and quinones in detergent micelles, making the two systems difficult to directly compare. Consistent with the UQ-1&#x02013;MK-1 kinetics, <italic>Ecbd</italic> showed a marginally higher catalytic rate with UQ-10 than MK-9 (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref><italic>A</italic>). In addition, <italic>Mtbd</italic> displayed the same specificity for MK turnover, confirming the quinone analog data (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref><italic>B</italic>). Substrate inhibition for <italic>Mtbd</italic> was confirmed by increasing the MK concentration from 0.25% to 1%, resulting in a significant decrease in enzyme activity.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p><bold>Quinone substrate specificity of <italic>Ecbd</italic> and <italic>Mtbd</italic> in a native lipid environment.</bold><italic>A</italic>, catalytic rates of <italic>Ecbd</italic> (20&#x000a0;nM) proteoliposomes containing 1% (molar; quinone/lipid) of either UQ-10 or MK-9. <italic>B</italic>, catalytic rates of <italic>Mtbd</italic> (20&#x000a0;nM) with different concentrations of either UQ-10 or MK-9 and inhibited by AurD. <italic>C</italic>, reconstituted <italic>Ecbd</italic> and <italic>Mtbd</italic> activity with native MK-9 (<italic>Ecbd</italic> 1% [molar; quinone/lipid] MK-9, <italic>Mtbd</italic> 0.25% [molar; quinone/lipid] MK-9) <italic>versus</italic> MK-1 analog (50&#x000a0;&#x003bc;M). Data are represented as the average and standard deviation from three individual proteoliposome reconstitutions. Significance is tested using an ANOVA with a Dunnett <italic>post hoc</italic> test in GraphPad Prism. &#x02217;<italic>p</italic>&#x000a0;&#x0003c; 0.05, &#x02217;&#x02217;&#x02217;&#x02217;<italic>p</italic>&#x000a0;&#x0003c; 0.0001. <italic>Ecbd</italic>, cytochrome <italic>bd</italic> from <italic>Escherichia coli</italic>; MK-9, menaquinone 9; <italic>Mtbd</italic>, cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic>; UQ-10, ubiquinone&#x000a0;10.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0065">To study the effect of the quinone isoprenoid chain on cyt <italic>bd</italic> activity, <italic>Ecbd</italic> and <italic>Mtbd</italic> were reconstituted in proteoliposomes, and turnover was measured with either membrane-embedded MK-9 or water-soluble MK-1. Surprisingly, the isoprenoid chain length of the quinone was shown to have a significant effect on the maximum catalytic rate of cyt <italic>bd</italic> (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref><italic>C</italic>). Utilizing the natural membranous quinones resulted in 10-fold lower catalytic rates, emphasizing the role of the isoprenoid tail in substrate binding, <italic>via</italic> either diffusion or binding kinetics. This highlights that previously reported catalytic rates using quinone analogs can substantially overestimate the catalytic rates achieved <italic>in&#x000a0;vivo</italic> (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib31" ref-type="bibr">31</xref>).</p></sec><sec id="sec1.3"><title><italic>Mtbd</italic> activity is regulated by a unique Q-loop disulfide bond</title><p id="p0070"><italic>Mtbd</italic> is characterized by a unique disulfide bond that was hypothesized to reduce the flexibility of the substrate binding Q-loop (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref><italic>A</italic>) and thereby confer a regulatory role for enzyme activity (<xref rid="bib14" ref-type="bibr">14</xref>). Previous studies examining this mechanism faced limitations, as they relied on chemical reductants, such as DTT, to reduce the quinone pool, which inadvertently affects the disulfide bond itself. Using NDH-2 to enzymatically reduce the quinone pool enables the comparison of <italic>Mtbd</italic> activity before and after incubation with chemical reductants to reduce the disulfide bond and probe its effects on <italic>Mtbd</italic> activity.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p><bold><italic>Mtbd</italic> regulation by the Q-loop disulfide bond.</bold><italic>A</italic>, cryo-EM structure of <italic>Mtbd</italic> (Protein Data Bank code: <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/7NKZ" id="intref0035">7NKZ</ext-link>) (<xref rid="bib14" ref-type="bibr">14</xref>) with heme groups (<italic>red</italic>), MK-9 (<italic>blue</italic>), and unique Q-loop disulfide bond (<italic>yellow</italic>). The structure was analyzed using ChimeraX (<xref rid="bib70" ref-type="bibr">70</xref>). <italic>B</italic>, <italic>Mtbd</italic> MK-1 kinetics in detergent micelles before and after treatment with TCEP (<italic>blue</italic>), DTT (<italic>purple</italic>), or 2-ME (<italic>orange</italic>). The reductants were maintained in the assay buffer to prevent the reformation of the disulfide bond. Significant inhibition of oxidase activity is observed after DTT or 2-ME treatment. <italic>C</italic>, <italic>Ecbd</italic> MK-1 kinetics in detergent micelles before and after DTT treatment. No difference is observed. <italic>D</italic>, oxidase activity of proteoliposomes containing <italic>Mtbd</italic> (0.25% MK-9) or <italic>Ecbd</italic> (1% MK-9) before and after DTT treatment. Significance is tested using an unpaired <italic>t</italic> test in GraphPad Prism. &#x02217;&#x02217;<italic>p</italic>&#x000a0;&#x0003c; 0.01. 2-ME, 2-mercaptoethanol; MK-9, menaquinone 9; <italic>Mtbd</italic>, cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic>; TCEP, Tris(2-carboxyethyl)phosphine.</p></caption><graphic xlink:href="gr5"/></fig></p><p id="p0075">Incubation of <italic>Mtbd</italic> with either DTT or 2-mercaptoethanol (2-ME) showed a significant reduction in oxidase activity (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref><italic>B</italic>). In addition to the decrease in <italic>Mtbd</italic> activity, the disulfide bond breakage eliminates MK substrate inhibition, strongly suggesting that the reduction of the disulfide bond changes the structure or dynamics of the quinone-binding pocket. Unexpectedly, preincubation with the reductant Tris(2-carboxyethyl)phosphine (TCEP) did not decrease <italic>Mtbd</italic> activity, indicating that interactions with the disulfide bond might be hindered by surface accessibility or charge repulsion, as confirmed by nonreducing SDS-PAGE (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S4</xref>). To verify that the chemical reductants only impact the disulfide bond and no other aspects of <italic>Mtbd</italic>, the same measurements were performed with <italic>Ecbd</italic>, which lacks the Q-loop disulfide bond (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref><italic>C</italic>). This confirms that there is no difference in <italic>Ecbd</italic> activity after treatment with DTT and consolidates the conclusion that the decrease in the activity of <italic>Mtbd</italic> stems from the reduction of the Q-loop disulfide bond.</p><p id="p0080">To ensure that the observed effects are not artifacts of the detergent environment, the measurements were repeated in our proteoliposomal system and corrected for liposomal MK-9 auto-oxidation (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S4</xref><italic>E</italic>). Again, the <italic>Ecbd</italic> activity remains unchanged by the DTT treatment, whereas the <italic>Mtbd</italic> activity decreased by approximately 75% (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref><italic>D</italic>).</p></sec><sec id="sec1.4"><title>Structural changes induced by the reduction of the Q-loop disulfide bond</title><p id="p0085">To investigate the structural changes induced by the reducing conditions on <italic>Mtbd</italic>, single-particle cryo-EM analysis was performed. The reduced <italic>Mtbd</italic> structure was solved at a global resolution of 3.1&#x000a0;&#x000c5;. This includes a 3 to 5&#x000a0;&#x000c5; micelle, with the protein resolved at a resolution of 2.3 to 2.7&#x000a0;&#x000c5; (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S5</xref>). The reduced structure reveals notable structural changes in the Q-loop region and previously unstructured helix-connecting loops as well as a phosphatidylethanolamine (PE) lipid above the MK and two cardiolipin molecules (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>A</italic>).<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p><bold>Structural changes induced by reduction of the <italic>Mtbd</italic> Q-loop disulfide bond.</bold><italic>A</italic>, cryo-EM structure of disulfide reduced <italic>Mtbd</italic>. <italic>B</italic>, increased local flexibility in the Q-loop after disulfide reduction, resulting in a density loss from V279 to L288. <italic>C</italic>, a salt bridge between Arg290 and Glu263 stabilizes the N-terminal part of the Q-loop. <italic>D</italic>, sequence alignment of the <italic>Mycobacterium tuberculosis</italic>, <italic>Mycobacterium smegmatis</italic>, and <italic>Corynebacterium glutamicum</italic> cyt <italic>bd</italic> Q-loop, showing the unique Arg290 participating in the stabilizing salt bridge. <italic>E</italic>, <italic>Mtbd</italic> kinetics after disulfide reduction. Exposure to ambient oxygen or 50&#x000a0;&#x003bc;M&#x000a0;H<sub>2</sub>O<sub>2</sub> for 30&#x000a0;min results in a regain of oxidase activity, together with a reformation of the bond. <italic>F</italic>, local changes in the MK9-binding pocket. Slight conformational changes are observed in Met398 and MK-9. MK-9, menaquinone 9; <italic>Mtbd</italic>, cytochrome <italic>bd</italic> from <italic>Mycobacterium tuberculosis</italic>.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0090">The PE lipid is positioned on top of the MK-9-binding pocket, stabilized <italic>via</italic> hydrogen bonding with Arg8 (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S6</xref><italic>A</italic>). Interestingly, Arg8 has also been suggested as one of the stabilizing interactions binding to the MK headgroup (<xref rid="bib14" ref-type="bibr">14</xref>). One cardiolipin phospholipid is bound to CydB, located in a similar position as the cardiolipin in cyt <italic>bd</italic>-II oxidase from <italic>E.&#x000a0;coli</italic> (Protein Data Bank [PDB] code: <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/7OY2" id="intref0010">7OY2</ext-link>) (<xref rid="bib18" ref-type="bibr">18</xref>). In addition, we assigned a second cardiolipin that is positioned superior to the first cardiolipin, occupying the same hydrophobic groove (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S6</xref><italic>B</italic>). Interestingly, mutations in this groove have been shown to affect <italic>Mtbd</italic> oxidase activity, further highlighting the stimulatory effect of cardiolipin (<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib37" ref-type="bibr">37</xref>).</p><p id="p0095">The overall RMSD of 0.39&#x000a0;&#x000c5; between the oxidized (PDB code: <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/7NKZ" id="intref0015">7NKZ</ext-link> (<xref rid="bib14" ref-type="bibr">14</xref>)) and the disulfide-reduced structure indicates relatively minor global structural changes. However, increased local flexibility is observed for the <italic>Mtbd</italic> Q-loop residues 279 to 288, as evidenced by a weak electron density, suggesting a disordered conformation in the reduced state (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>B</italic>). To not bias our view of the Q-loop, we did not perform any micelle subtraction, as this could potentially remove electron density from the Q-loop region that is in close proximity to the micelle, leading to an inaccurate interpretation of the loop's structure and flexibility. Nevertheless, attempts to confidently model the Q-loop residues 279 to 288 were unsuccessful. The unstructured region within the Q-loop includes Cys285, which forms a disulfide bond with Cys266 under oxidized conditions. The especially weak electron density, as compared to the entire N-terminal region of the Q-loop, further confirms the breakage of this disulfide bond in the reduced structure.</p><p id="p0100">In contrast to the homologous cyt <italic>bd</italic> oxidases in <italic>Mycobacterium smegmatis</italic> and <italic>C.&#x000a0;glutamicum</italic>, where the entire N-terminal region of the Q-loop is disordered (<xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib38" ref-type="bibr">38</xref>), the <italic>Mtbd</italic> Q-loop remains partially structured. Although <italic>bd</italic> oxidases from <italic>M.&#x000a0;smegmatis</italic> and <italic>C.&#x000a0;glutamicum</italic> contain the conserved cysteine residues, they do possess a disulfide bond under the conditions tested (<xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib38" ref-type="bibr">38</xref>). This suggests that the <italic>Mtbd</italic> Q-loop possesses additional stabilizing interactions that help maintain a semistructured conformation even after disulfide reduction. This could be attributed to the presence of Arg290 in <italic>Mtbd</italic>, which forms a salt bridge with Glu263, thereby stabilizing the remaining Q-loop (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>C</italic>). Arg290 is unique to <italic>Mtbd</italic>, as the homologous cyt <italic>bd</italic> oxidases in <italic>M.&#x000a0;smegmatis</italic> and <italic>C.&#x000a0;glutamicum</italic> possess a histidine in the corresponding position (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>D</italic>) and could explain the fully unstructured N-terminal Q-loop observed in these homologs.</p><p id="p0105">The salt bridge might help to maintain spatial proximity between Cys266 and Cys285 and facilitate the eventual reformation of the disulfide bond, suggesting a potential regulatory mechanism for <italic>Mtbd</italic> activity. Indeed, exposure of the reduced <italic>Mtbd</italic> to ambient oxygen concentrations resulted in a &#x0223c;30% recovery of activity, followed by near full recovery after exposure to 50&#x000a0;&#x003bc;M H<sub>2</sub>O<sub>2</sub>. The activity regain was accompanied by reformation of the disulfide bond, as confirmed by nonreducing SDS-PAGE (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>E</italic>).</p><p id="p0110">Despite the local changes in the Q-loop upon disulfide reduction, MK-9 remains tightly bound near Trp9. A minor shift of Met397 is observed, increasing its distance to the MK-9 headgroup from 3.6 to 3.8&#x000a0;&#x000c5; (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref><italic>F</italic>). In addition, we observe a slight shift of MK-9 out of the binding pocket, increasing its distance to Trp9 from 3.7 to 3.9&#x000a0;&#x000c5;.</p><p id="p0115">Importantly, however, the minor structural changes around MK-9 likely cannot account for the observed decrease in enzyme activity. We hypothesize that the observed MK-9 plays a structural role rather than serving as the substrate, which is supported by the cryo-EM density maps of <italic>Mtbd</italic> in the presence of the potent quinone-analog inhibitors AurD (<xref rid="bib14" ref-type="bibr">14</xref>) and AD3-11 (<xref rid="bib39" ref-type="bibr">39</xref>) (EMD-12532 and EMD-12533) (<xref rid="bib14" ref-type="bibr">14</xref>). Despite a vast molar excess of these inhibitors, the MK-9 density remains unaltered, suggesting that the inhibitors occupy a different binding pocket while <italic>Mtbd</italic> is fully inhibited (<xref rid="bib14" ref-type="bibr">14</xref>). This indicates the existence of a separate substrate binding site, potentially between heme <italic>b</italic><sub>558</sub> and the Q-loop, as hypothesized in other cyt <italic>bd</italic> oxidases (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>).</p></sec></sec><sec id="sec2"><title>Discussion</title><p id="p0120">Cyt <italic>bd</italic> is a critical part of the prokaryotic respiratory chain to maintain ATP regeneration under microaerobic conditions (<xref rid="bib3" ref-type="bibr">3</xref>). <italic>Mtbd</italic> has been highlighted for its essentiality under oxygen-limiting conditions and its related interest as an antibiotic target against <italic>M.&#x000a0;tuberculosis</italic> (<xref rid="bib5" ref-type="bibr">5</xref>). Most current knowledge, however, comes from mechanistic studies on homologous enzymes such as <italic>Ecbd</italic> and <italic>C.&#x000a0;glutamicum</italic> cyt <italic>bd</italic>, which have diverse structural features, such as a lack of the characteristic <italic>Mtbd</italic> Q-loop disulfide bond (<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>).</p><p id="p0125">The minimal respiratory chain, both in detergent and liposomes, unambiguously indicates that <italic>Ecbd</italic> can oxidize UQ, MK, and DMK. The affinity of <italic>Ecbd</italic> for UQ-1 (<italic>K</italic><sub>m</sub>: 149&#x000a0;&#x000b1;&#x000a0;26&#x000a0;&#x003bc;M) is in line with previously reported values (<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>), whereas the catalytic rate at 200&#x000a0;&#x003bc;M UQ-1 (1268&#x000a0;&#x000b1;&#x000a0;81 <italic>e</italic><sup>&#x02212;</sup> s<sup>&#x02212;1</sup>) is higher than the literature-reported values (889&#x000a0;&#x000b1;&#x000a0;30 <italic>e</italic><sup>&#x02212;</sup> s<sup>&#x02212;1</sup>) (<xref rid="bib16" ref-type="bibr">16</xref>) and is attributed to the difference in the detergent environment and assay conditions. The fact that we see activity with MK is in direct contrast with an earlier study that suggests that <italic>Ecbd</italic> cannot oxidize MK (<xref rid="bib18" ref-type="bibr">18</xref>). We note that in this earlier study, MK was reduced by DTT. Indeed, when we repeated the assay with DTT instead of NADH&#x02013;NDH-2 to reduce MK, we did not observe any activity. Here, we propose that although DTT is a good reductant for UQ and hence a good reductant to measure oxygen-reducing activity by cyt <italic>bd</italic>, DTT might be a poor reductant and rate limiting when the assay is performed with MK. The observation that <italic>Ecbd</italic> can oxidize MK and DMK is consistent with the <italic>in&#x000a0;vivo</italic> upregulation of MK and DMK during microaerobic respiration, conditions that also lead to increased expression of <italic>Ecbd</italic> (<xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib42" ref-type="bibr">42</xref>).</p><p id="p0130">The catalytic rates of both <italic>Ecbd</italic> and <italic>Mtbd</italic> were approximately 10-fold lower when using the natural lipophilic quinones in comparison to their often-used water-soluble analogs. Similar effects have been shown before, where small differences in quinone isoprenoid units altered turnover rate (<xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref>). This highlights the need for physiologically relevant assay conditions to obtain appropriate kinetic rates and inhibition values. The difference in activity when using the native quinones could be explained by a difference in binding or diffusion kinetics, as many of the quinone-bound oxidase structures have shown that the quinone isoprenoid tails play a significant role in substrate&#x02013;enzyme interactions (<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib45" ref-type="bibr">45</xref>), and longer chains might result in slower substrate binding and release (<xref rid="bib46" ref-type="bibr">46</xref>).</p><p id="p0135"><italic>Mtbd</italic> exclusively catalyzes MK oxidation, while competition experiments suggest that UQ and DMK can bind to the same active site. A similar phenomenon was shown for cyt <italic>bd</italic> from <italic>C.&#x000a0;glutamicum</italic>, and cytochrome <italic>bcc</italic> from <italic>M.&#x000a0;tuberculosis</italic>, which also lacked oxidase activity using UQ as a substrate (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib43" ref-type="bibr">43</xref>). We postulate that this lack of UQ-1 turnover in <italic>C.&#x000a0;glutamicum</italic> cyt <italic>bd</italic> is caused by a thermodynamic barrier between two-electron oxidation of UQ (100&#x000a0;mV) and the single-electron acceptor heme <italic>b</italic> (102&#x000a0;mV) (<xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib47" ref-type="bibr">47</xref>). Similar suggestions have been made for mycobacterial cytochrome <italic>bcc</italic>, where the heme redox potentials are too low to allow the oxidation of UQ (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib48" ref-type="bibr">48</xref>). Although the heme potentials for <italic>Mtbd</italic> are unknown, we postulate that the same thermodynamic barrier applies here.</p><p id="p0140"><italic>Mtbd</italic> was unable to oxidize DMK, which is similar in structure to MK, and has a reduction potential that lies in between that of MK and UQ. In <italic>M.&#x000a0;tuberculosis</italic>, DMK is a precursor in MK biosynthesis. Small-molecule inhibitors of MenG, the enzyme that converts DMK into MK, were bactericidal in <italic>M.&#x000a0;tuberculosis</italic> (<xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref>). This substantiates the inability of <italic>Mtbd</italic> to turn over DMK and highlights the tight specificity between the quinone pool and <italic>Mtbd</italic>. In addition, this emphasizes that inhibition of MK biosynthesis is a valid antibiotic strategy that targets the fundamental electron transfer steps between the respiratory chain components.</p><p id="p0145">In contrast to our observation reported here, <italic>Mtbd</italic> expressed in <italic>E.&#x000a0;coli</italic> has been reported to oxidize UQ when assayed in crude membrane extracts (<xref rid="bib44" ref-type="bibr">44</xref>). Potentially, the observed UQ oxidation was caused by interfering oxidases present in the membrane extracts, such as <italic>E.&#x000a0;coli</italic> cyt <italic>bd</italic>-II. Further studies would be required to determine why the assay in crude <italic>E.&#x000a0;coli</italic> membrane extracts gives rise to different results than <italic>Mtbd</italic> purified from <italic>M.&#x000a0;smegmatis</italic>, as reported here.</p><p id="p0150">Based on our structural analysis of <italic>Mtbd</italic>, we suggest that the observed MK-9 in the binding pocket adjacent to Trp9 confers a structural role rather than acting as the substrate under the conditions tested. The published structure (<xref rid="bib14" ref-type="bibr">14</xref>) and our structure of the disulfide reduce <italic>Mtbd</italic>, do not indicate an alternative quinone substrate-binding site, and it is therefore critical to uncover and prove the cyt <italic>bd</italic> quinone substrate-binding pocket in the future. While the location of the <italic>Mtbd</italic> catalytic site remains speculative, studies on the homologs <italic>Ecbd</italic> (<xref rid="bib16" ref-type="bibr">16</xref>) and <italic>Ecbd</italic>-II (<xref rid="bib5" ref-type="bibr">5</xref>) have indicated binding at the N-terminal part of the Q-loop, stabilized by Arg245 near heme b<sub>585</sub>. Whether these results translate to <italic>Mtbd</italic> remains unclear. The binding of a quinone substrate might be correlated to structural changes in which the disulfide bond has a more pronounced role, possibly explaining the role of the disulfide bond on the activity of <italic>Mtbd</italic>.</p><p id="p0155">The <italic>Mtbd</italic> disulfide bond is unique among the currently studied cyt <italic>bd</italic> oxidases. Despite the conservation of these cysteine residues in <italic>M.&#x000a0;smegmatis</italic> (<xref rid="bib38" ref-type="bibr">38</xref>) and <italic>C.&#x000a0;glutamicum</italic> (<xref rid="bib15" ref-type="bibr">15</xref>) cyt <italic>bd</italic>, these proteins do not show a formed cysteine bond in their structures under the conditions tested. Here, we show that the chemical reduction of the <italic>Mtbd</italic> disulfide bond results in a significant decrease in oxidase activity. Molecular dynamics studies previously suggested that reduction of the <italic>Mtbd</italic> disulfide bond greatly increases Q-loop flexibility (<xref rid="bib14" ref-type="bibr">14</xref>). In contrast, the structure of the disulfide-reduced <italic>Mtbd</italic> indicates only minor structural changes outside the Q-loop, whereas the Q-loop itself also remains mostly structured except for residues 279 to 288. In the structure of the disulfide-reduced state, the cysteines remain in relatively close proximity, possibly aided by a salt bridge between Arg290 and Glu263, which could explain why the disulfide bond in <italic>Mtbd</italic> can fully (re)form upon exposure to hydrogen peroxide.</p><p id="p0160">This redox sensory role of the Q-loop disulfide bond might contribute to a rapid adaptation of <italic>M.&#x000a0;tuberculosis</italic> when exposed to the hostile conditions encountered during infection. We hypothesize that <italic>Mtbd</italic> is expressed and maintained in the disulfide-reduced state, allowing for efficient respiration using the cytochrome <italic>bcc</italic>:<italic>aa</italic><sub>3</sub> branch. This is in line with our results, showing that <italic>Mtbd</italic> maintains mostly reduced upon exposure to ambient oxygen. This primes <italic>Mtbd</italic> to be activated upon exposure to the ROS encountered during phagocytosis. Our hypothesis could also explain the instantaneous increase in respiration by <italic>M.&#x000a0;tuberculosis</italic> upon inhibition of the <italic>bcc:aa</italic><sub><italic>3</italic></sub> supercomplex (<xref rid="bib20" ref-type="bibr">20</xref>), which is shown to also increase periplasmic ROS. The disulfide bond of <italic>Mtbd</italic> might be further regulated by the large network of proteins and small molecules controlling <italic>M.&#x000a0;tuberculosis</italic> redox homeostasis (<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>). How this regulatory mechanism would play into the larger metabolic response of <italic>M.&#x000a0;tuberculosis</italic> to ROS remains unknown, especially in the rapid time frames <italic>Mtbd</italic> shows to be activated (<xref rid="bib21" ref-type="bibr">21</xref>).</p><p id="p0165">To our knowledge, this is the first proof of a terminal oxidase under the regulation of a redox-sensing disulfide bond. Enzyme-level regulation of <italic>Mtbd</italic> with different redox pressures might be important for <italic>M.&#x000a0;tuberculosis</italic> to reroute electrons from cytochrome <italic>bcc</italic>:<italic>aa</italic><sub>3</sub> to <italic>Mtbd</italic>, rapidly adapting to environmental changes. Potentially, this aids in the survival in ROS-rich environments during infection (<xref rid="bib53" ref-type="bibr">53</xref>, <xref rid="bib54" ref-type="bibr">54</xref>), with the suggested role of <italic>Mtbd</italic> in hydrogen peroxide resistance (<xref rid="bib55" ref-type="bibr">55</xref>). In addition, <italic>Ecbd</italic> has been shown to actively detoxify the cellular environment from hydrogen peroxide (<xref rid="bib56" ref-type="bibr">56</xref>) and peroxynitrite (<xref rid="bib57" ref-type="bibr">57</xref>), indicating potential additional roles for <italic>Mtbd</italic> as a survival factor for <italic>M.&#x000a0;tuberculosis</italic>. Future research should focus on the physiological role and regulation of the <italic>Mtbd</italic> disulfide bond and its influence on <italic>M.&#x000a0;tuberculosis</italic> survival. Additional investigations of the interplay between <italic>Mtbd</italic> and environmental redox pressures, especially regarding its potential detoxifying role as seen with <italic>Ecbd</italic> (<xref rid="bib56" ref-type="bibr">56</xref>), will offer valuable insights into the adaptive role of <italic>Mtbd</italic> in the defense against ROS and antibiotic compounds encountered during infection.</p></sec><sec id="sec3"><title>Experimental procedures</title><sec id="sec3.1"><title>Expression and purification of <italic>E.&#x000a0;coli</italic> cyt <italic>bd</italic>-I</title><p id="p0170">The expression of <italic>E.&#x000a0;coli</italic> cytochrome <italic>bd</italic>-I (<italic>Ecbd</italic>) was performed as previously described (<xref rid="bib58" ref-type="bibr">58</xref>), with slight modifications. Briefly, MB43&#x000a0;cells (<xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib60" ref-type="bibr">60</xref>) transformed with pET17b-CydABX-linkerstreptag were grown overnight in LB with 100&#x000a0;&#x003bc;g/ml ampicillin (250 RPM, 37 &#x000b0;C). The culture was diluted to an absorbance of &#x0223c;0.1 in LB ampicillin and grown to an absorbance of &#x0223c;0.4. Expression was induced by the addition of 0.45&#x000a0;mM IPTG and carried out until an absorbance of &#x0223c;2.0. Cells were harvested by centrifugation (6371 rcf, 20&#x000a0;min, 4 &#x000b0;C) and resuspended in 50&#x000a0;mM Mops, pH 7.4, 100&#x000a0;mM NaCl, cOmplete EDTA-free Protease Inhibitor (ROCHE), at 1&#x000a0;g wet cells per 5&#x000a0;ml buffer. Cells were disrupted by a single pass through a Stansted pressure cell homogenizer (270&#x000a0;MPa). Unbroken cells were pelleted and discarded by centrifugation (10,000 rcf, 20&#x000a0;min, 4 &#x000b0;C). Crude membranes were isolated by ultracentrifugation (200,000 rcf, 1h, 4 &#x000b0;C) and resuspended to 10&#x000a0;mg/ml protein concentration in 50&#x000a0;mM Mops, 100&#x000a0;mM NaCl, pH 7.4. Detergent extraction of the membrane proteins was performed by incubation with 0.5% lauryl maltose neopentyl glycol (LMNG) for 1&#x000a0;h at 4 &#x000b0;C with gentle mixing. Insoluble material was pelleted and discarded by ultracentrifugation (200,000 rcf, 30&#x000a0;min, 4 &#x000b0;C) followed by application of the soluble fraction to a StrepTrap HP column (Cytiva) at 1&#x000a0;ml/min. To remove unbound proteins, the column was washed with 50&#x000a0;mM sodium phosphate, 300&#x000a0;mM NaCl, 0.005% LMNG, pH 8.0. Elution was performed by the addition of 50&#x000a0;mM sodium phosphate, 300&#x000a0;mM NaCl, 2.5&#x000a0;mM desthiobiotin, 0.005% LMNG, pH 8.0, after which purity was confirmed by SDS-PAGE. Fractions containing pure <italic>E.&#x000a0;coli</italic> cyt <italic>bd</italic>-I were pooled, concentrated, and stored at&#x000a0;&#x02212;80 &#x000b0;C until further use.</p></sec><sec id="sec3.2"><title>Expression and purification of <italic>M.&#x000a0;tuberculosis</italic> cyt <italic>bd</italic></title><p id="p0175"><italic>Mtbd</italic> expression and purification were performed as previously described with slight modifications (<xref rid="bib14" ref-type="bibr">14</xref>). <italic>M.&#x000a0;smegmatis</italic> MC (<xref rid="bib2" ref-type="bibr">2</xref>) 155 &#x00394;CydAB (<xref rid="bib61" ref-type="bibr">61</xref>) was transformed with the pLHCyd plasmid using electroporation with an Eppendorf eporator (2.5&#x000a0;kV). Positive transformants were selected by plating the cells on LB agar with 50&#x000a0;&#x003bc;g/ml hygromycin. A starter culture was inoculated in LB&#x02013;hygromycin and grown for 72&#x000a0;h (250 RPM, 37 &#x000b0;C). The culture was diluted 1:100 and grown for an additional 72&#x000a0;h (200 RPM, 37 &#x000b0;C) until the cells were harvested (6371 rcf, 20&#x000a0;min, 4 &#x000b0;C) and resuspended in a fivefold volume of 50&#x000a0;mM Tris&#x02013;HCl (pH 7.4), 5&#x000a0;mM MgCl<sub>2</sub>, 0.05% Tween-80, and cOmplete EDTA-free Protease Inhibitor. The cells were lysed by a double pass through a Stansted pressure cell homogenizer (270&#x000a0;MPa). Cell debris was pelleted and discarded by centrifugation at 10,000 rcf, 20&#x000a0;min at 4 &#x000b0;C. The crude membranes were extracted by ultracentrifugation (200,000 rcf, 1&#x000a0;h, 4 &#x000b0;C) and resuspended in 20&#x000a0;mM Tris&#x02013;HCl, pH 7.4, 0.05% Tween-80, and 10% glycerol to a total protein concentration of 10&#x000a0;mg/ml. The proteins were solubilized by the addition of 0.5% LMNG with gentle mixing (1 h, 4 &#x000b0;C). Insoluble material was pelleted by ultracentrifugation (200,000 rcf, 30&#x000a0;min, 4 &#x000b0;C) and discarded. The soluble fraction was incubated overnight at 4 &#x000b0;C with Pierce Anti-DYKDDDDK Affinity Resin (ThermoFisher) and purified according to the manufacturer&#x02019;s instructions. Briefly, the flow through was removed by centrifugation at 1000 rcf, followed by four washing steps with 10 colume volumes of 50&#x000a0;mM Tris&#x02013;HCl (pH 7.4), 150&#x000a0;mM NaCl, and 0.005% LMNG. The protein was eluted by the addition of 50&#x000a0;mM Tris&#x02013;HCl (pH 7.4), 150&#x000a0;mM NaCl, 0.02% dodecyl beta-<sc>d</sc>-maltoside (DDM), 1&#x000a0;mg/ml 3X-FLAG peptide (Genscript). Final purification was achieved by SEC on a Superdex 200 increase 10/200 column at 0.5&#x000a0;ml/min (50&#x000a0;mM Tris&#x02013;HCl [pH 7.4], 150&#x000a0;mM NaCl, and 0.005% LMNG). SEC peak fractions were evaluated on SDS-gel, and pure <italic>Mtbd</italic> was pooled, concentrated, and stored at&#x000a0;&#x02212;80 &#x000b0;C until further use.</p></sec><sec id="sec3.3"><title>Expression and purification of NDH-2</title><p id="p0180">The gene for <italic>C.&#x000a0;thermarum</italic> NDH-2 with an N-terminal hexahistidine tag was ordered from GeneArt and cloned in the pET28 vector between NcoI and XhoI, giving rise to the construct pET28-NDH-2_NtermHis. pET28-NDH-2_NtermHis was transformed into C41 (DE3) cells and plated on LB kanamycin to select positive transformants.</p><p id="p0185">Expression and purification were performed based on the procedure from Heikal <italic>et&#x000a0;al.</italic> (<xref rid="bib62" ref-type="bibr">62</xref>) with slight modifications. Briefly, a streak of transformants was inoculated and grown overnight (250 RPM, 37 &#x000b0;C). The overnight culture was diluted to absorbance of 0.1 in LB kanamycin and grown to an absorbance of 0.5 before induction with 0.25&#x000a0;mM IPTG. Expression was carried out for 4&#x000a0;h before cells were harvested (6371 rcf, 20&#x000a0;min, 4 &#x000b0;C). The cells were resuspended in a fivefold volume of 50&#x000a0;mM Tris&#x02013;HCl, 5&#x000a0;mM MgCl<sub>2</sub>, pH 8.0, and lysed by a single pass through a Stansted pressure cell homogenizer (270&#x000a0;MPa). Unbroken cells were pelleted by centrifugation (10,000 rcf, 20&#x000a0;min, 4 &#x000b0;C) and discarded. Crude membrane fractions were pelleted by ultracentrifugation (200,000 rcf, 1 h, 4 &#x000b0;C) and resuspended at a 10&#x000a0;mg/ml total protein concentration in Tris&#x02013;HCl, 150&#x000a0;mM NaCl, and 20&#x000a0;mM imidazole. Membrane proteins were extracted by treatment with 1% DDM for 1&#x000a0;h at 4 &#x000b0;C with gentle mixing. The membranes were removed by ultracentrifugation (200,000 rcf, 30&#x000a0;min, 4 &#x000b0;C) followed by application of the soluble fraction to a HiTrap Nickel NTA column (Cytiva). The unbound proteins were washed from the column with washing buffer (50&#x000a0;mM Tris&#x02013;HCl [pH 8.0], 150&#x000a0;mM NaCl, 20&#x000a0;mM imidazole, and 0.02% DDM) followed by elution using stepwise addition of elution buffer (50&#x000a0;mM Tris&#x02013;HCl, 150&#x000a0;mM NaCl, 500&#x000a0;mM imidazole, and 0.02% DDM). NDH-2 eluted at approximately 30% elution buffer, as confirmed by SDS-PAGE gel and Western blot. Final purification was achieved by SEC on a Superdex increase 200 10/300 column (Cytiva) at 0.5&#x000a0;ml/min (50&#x000a0;mM Tris&#x02013;HCl [pH 8.0], 500&#x000a0;mM NaCl, 5% glycerol, and 0.02% DDM). Pure fractions were pooled, concentrated, and stored at&#x000a0;&#x02212;80 &#x000b0;C until further use.</p></sec><sec id="sec3.4"><title>Cyt <italic>bd</italic> reconstitution in proteoliposomes</title><p id="p0190">Lipids were purchased from Avanti Polar Lipids and used as received. A lipid mixture of POPE:POPG:CA (60:30:10 for <italic>Ecbd</italic> proteoliposomes, 30:60:10 for <italic>Mtbd</italic> proteoliposomes), enriched with the desired concentrations of UQ-10 (Sigma) or MK-9 (Cayman Chemical), was dried under a stream of nitrogen. Final traces of CHCl<sub>3</sub> were removed overnight under vacuum. The lipid film was rehydrated and resuspended to a final concentration of 10&#x000a0;mg/ml in 20&#x000a0;mM Mops, 30&#x000a0;mM Na<sub>2</sub>SO<sub>4</sub>, 100&#x000a0;mM KCl, pH 7.4, by vortexing. Cyt <italic>bd</italic> reconstitution was performed as described (<xref rid="bib63" ref-type="bibr">63</xref>). Briefly, cyt <italic>bd</italic> was added to the liposome solution at 1 w/w% protein/lipids and mixed for 30&#x000a0;min by inversion at room temperature. Insoluble materials were removed by centrifugation in an Eppendorf tabletop centrifuge (14,100 rcf, 5&#x000a0;min). The proteoliposome cyt <italic>bd</italic> concentration was determined by redissolving a sample in 2% octyl-&#x003b2;-glucoside, followed by quantification of the Soret band with the corresponding extinction coefficient (<italic>Ecbd</italic>: &#x003b5;<sub>417</sub> 230&#x000a0;mM<sup>&#x02212;1</sup>&#x000a0;cm<sup>&#x02212;1</sup> (<xref rid="bib64" ref-type="bibr">64</xref>), <italic>Mtbd</italic>: &#x003b5;<sub>414</sub> 279&#x000a0;mM<sup>&#x02212;1</sup>&#x000a0;cm<sup>&#x02212;1</sup>). The latter extinction coefficient of the <italic>Mtbd</italic> Soret band (414&#x000a0;nm) was determined from UV&#x02013;vis absorbance in relation to protein concentrations determined by bicinchoninic assay from three different protein preparations. The extinction coefficient (&#x003b5;<sub>414nm</sub>&#x000a0;=&#x000a0;279&#x000a0;&#x000b1;&#x000a0;13&#x000a0;mM<sup>&#x02212;1</sup>&#x000a0;cm<sup>&#x02212;1</sup>) was comparable to other <italic>bd</italic>-type oxidases (<xref rid="bib29" ref-type="bibr">29</xref>).</p></sec><sec id="sec3.5"><title>Enzyme kinetics with water-soluble quinone analogs</title><p id="p0195">Oxygen consumption of LMNG-solubilized cyt <italic>bd</italic> with quinone analogs was measured on an oxygraph (Hansatech Ltd) system at 20 &#x000b0;C. The quinone analogs, UQ-1 (Sigma), deoxylapachol (DMK-1; MedChem Express), or MK-1 (Santa Cruz Biotech), were added to the reaction chamber at the desired concentration in 50&#x000a0;mM Mops (pH 7.0), 150&#x000a0;mM NaCl, and 0.005% LMNG. Quinone-mediated auto-oxidation was determined by enzymatic reduction of the quinones by <italic>C.&#x000a0;thermarum</italic> NDH-2 (30&#x000a0;nM) after the addition of 1&#x000a0;mM NADH. Oxygen consumption was initiated by the addition of cyt <italic>bd</italic> (4&#x000a0;nM for <italic>Ecbd</italic> and 6.5&#x000a0;nM for <italic>Mtbd</italic>). The enzyme activity was measured by subtraction of the quinone auto-oxidation rate from the initial slope after cyt <italic>bd</italic> addition. The kinetics curves were fit, and where possible, enzymatic parameters were determined using GraphPad Prism (GraphPad Software, Inc) using either Michaelis&#x02013;Menten equation (Equation&#x000a0;<xref rid="fd1" ref-type="disp-formula">1</xref>) or substrate inhibition kinetics (Equation&#x000a0;<xref rid="fd2" ref-type="disp-formula">2</xref>).<disp-formula id="fd1"><label>(1)</label><mml:math id="M1" altimg="si1.svg" alttext="Equation1."><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>E</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="fd2"><label>(2)</label><mml:math id="M2" altimg="si2.svg" alttext="Equation2."><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>E</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec3.6"><title>Cyt <italic>bd</italic> oxygen consumption in proteoliposomes</title><p id="p0200">Oxygen consumption was measured on an oxygraph system at 20 &#x000b0;C. Prior to the measurement, cyt <italic>bd</italic> proteoliposomes were diluted to the desired concentration (20&#x000a0;nM cyt <italic>bd</italic>) in 50&#x000a0;mM Mops, 150&#x000a0;mM NaCl, pH 7.0. The proteoliposomes were incubated for 30&#x000a0;min at room temperature with 100&#x000a0;nM NDH-2 to complete the proteoliposomal system. Oxygen consumption was initiated by the addition of 1&#x000a0;mM NADH. The oxygen consumption rate was quantified using the initial slope after NADH addition and corrected for auto-oxidation from cyt <italic>bd</italic>-free liposomes.</p></sec><sec id="sec3.7"><title>Cyt <italic>bd</italic> oxygen consumption after treatment with reductants</title><p id="p0205">The effect of <italic>Mtbd</italic> Q-loop disulfide bond reduction was studied by 30&#x000a0;min of preincubation with chemical reductants (10&#x000a0;mM TCEP, 10&#x000a0;mM DTT, or 100&#x000a0;mM 2-ME). When required, the reductant was removed by spin filtration before exposure to either ambient oxygen concentration or 50 &#x003bc;M H<sub>2</sub>O<sub>2</sub> for 30&#x000a0;min. The samples were diluted to the concentrations used previously in the LMNG-solubilized or proteoliposomal measurements. The buffer was supplemented with the respective chemical reductant to maintain the reductive environment during the measurement (1&#x000a0;mM TCEP [10&#x000a0;mM showed auto-oxidation]), 10&#x000a0;mM DTT, and 100&#x000a0;mM 2-ME). The measurements were performed as mentioned previously.</p></sec><sec id="sec3.8"><title>Nonreducing SDS-PAGE</title><p id="p0210">The effects of environmental redox potentials on the <italic>Mtbd</italic> disulfide bond were determined by nonreducing SDS page, omitting reductant from the loading buffer. <italic>Mtbd</italic> was exposed to the desired amount of reductant (10&#x000a0;mM DTT) for 1&#x000a0;h, before removal by spin filtration. If required, <italic>Mtbd</italic> was exposed to ambient oxygen concentrations or 50&#x000a0;&#x003bc;M&#x000a0;H<sub>2</sub>O<sub>2</sub> for 30&#x000a0;min before denaturation in SDS-PAGE buffer without additional reductant. Shifts in the <italic>Mtbd</italic> CydA protein band were determined by nonreducing SDS-PAGE gel.</p></sec><sec id="sec3.9"><title>Cryo-EM sample preparation and data collection</title><p id="p0215">C-flat R1.2/1.3-Cu 300 mesh grids (Electron Microscopy Sciences) were freshly glow discharged with PELCO easiGlow device at 15&#x000a0;mA for 90&#x000a0;s. LMNG-solubilized <italic>Mtbd</italic> was pretreated with 4&#x000a0;mM DTT for 1&#x000a0;h to break the Q-loop disulfide bond, followed by the application of 4&#x000a0;&#x003bc;l sample (2.5&#x000a0;mg/ml) on the grid. Sample blotting was performed for 3&#x000a0;s, at 20 blot force using a Vitrobot IV device (ThermoFisher Scientific) operating at 4 &#x000b0;C and 100% relative humidity, directly before plunge freezing into liquid ethane.</p><p id="p0220">A total of 14,078 movies were collected on a Titan Krios G1 (ThermoFisher Scientific) operating at 300&#x000a0;kV, equipped with a Gatan K3 detector and BioQuantum energy filter with a slit width of 20&#x000a0;eV. Movies were acquired in electron counting mode using aberration-free image-shift in EPU (ThermoFisher Scientific). A total dose of 100 e/&#x000c5;2 with 100 frames, at 105,000&#x000d7; magnification with a calibrated pixel size of 0.836&#x000a0;&#x000c5; and a defocus range of 1.0 to 2.0&#x000a0;&#x003bc;m.</p></sec><sec id="sec3.10"><title>Cryo-EM data analysis</title><p id="p0225">CryoSPARC live (<xref rid="bib65" ref-type="bibr">65</xref>) was used for on-the-fly processing of data with motion correction using patch motion correction, contrast transfer function (CTF) estimation using patch CTF estimation, and particle picking based on Blob-picker using minimum/maximum diameters and filtering based on normalized cross-correlation score and Power score. Curated micrographs were imported into the regular version of CryoSPARC (version 4.3.1) for further processing. After importing filtered micrographs and 2D class templates from the live session, Template-picker was used to fine-tune the picking parameters. Multiple rounds of 2D classification were run to clean junk particles. An unsupervised <italic>ab initio</italic> map was built, and the map and extracted particles were taken further to multiple rounds of heterogeneous refinement. Only the best particles along with all volumes were taken to further heterogeneous refinement jobs until particles became constant in the best class. Particles from the best class were taken to nonuniform refinement jobs for global and local CTF refinements along with other high-order aberration corrections (<xref rid="bib66" ref-type="bibr">66</xref>). Movies were taken to another motion correction job to remove the last 50 frames, in order to check for any particle damage from relatively higher electron dose in the later frames. These movies and particles from last refinement job were used to re-extract with the original box size. This was further taken to several more rounds of nonuniform refinements. Data processing was finished by achieving a high-resolution subatomic map of 2.96 &#x000c5;. During the data processing, LMNG micelle was not subtracted from the maps, so as not to create any signal biasedness between detergent micelle and flexible parts of the protein.</p></sec><sec id="sec3.11"><title>Model building</title><p id="p0230">Model building was done using <italic>Mtbd</italic> model from <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/7NKZ" id="intref0020">7NKZ</ext-link> and fitting main chains using ARP/wARP server. After the main chain fitting, all side chains were manually checked and fitted, and missing loops and termini were added in Coot software (version 0.9) (<xref rid="bib67" ref-type="bibr">67</xref>), and missing residues from loops, N and C termini were added. Cardiolipins and PE were added to the designated density in <italic>Mtbd</italic>. Models and the corresponding maps were assessed and analyzed in ChimeraX (version 1.7.1) (<xref rid="bib68" ref-type="bibr">68</xref>).</p></sec></sec><sec sec-type="data-availability" id="sec4"><title>Data availability</title><p id="p0235">The cryo-EM map file of disulfide-reduced <italic>Mtbd</italic> was deposited in the EMD database and can be found under accession number EMD-50520. The model file of <italic>Mtbd</italic> was deposited to the PDB under <ext-link ext-link-type="PDB" xlink:href="https://www.rcsb.org/9FKA" id="intref0025">9FKA</ext-link>.</p></sec><sec sec-type="supplementary-material" id="sec6"><title>Supporting information</title><p id="p0240">This article contains <xref rid="sec1" ref-type="sec">supporting information</xref> (<xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib69" ref-type="bibr">69</xref>).</p></sec><sec sec-type="COI-statement" id="coi0010"><title>Conflict of interest</title><p id="p0250">The authors declare that they have no conflicts of interest with the contents of this article.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Belevich</surname><given-names>I.</given-names></name><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Bloch</surname><given-names>D.A.</given-names></name><name><surname>Konstantinov</surname><given-names>A.A.</given-names></name><name><surname>Verkhovsky</surname><given-names>M.I.</given-names></name></person-group><article-title>Cytochrome bd from Azotobacter vinelandii: evidence for high-affinity oxygen binding</article-title><source>Biochemistry</source><volume>46</volume><year>2007</year><fpage>11177</fpage><lpage>11184</lpage><pub-id pub-id-type="pmid">17784736</pub-id>
</element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>D&#x02019;mello</surname><given-names>R.</given-names></name><name><surname>Hill</surname><given-names>S.</given-names></name><name><surname>Poolel</surname><given-names>R.K.</given-names></name></person-group><article-title>The cytochrome bd quinol oxidase in Escherichia coli has an extremely high oxygen affinity and two oxygen-binding haems: implications for regulation of activity <italic>in vivo</italic> by oxygen inhibition</article-title><source>Microbiology</source><volume>142</volume><year>1996</year><fpage>755</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">8936304</pub-id>
</element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Siletsky</surname><given-names>S.A.</given-names></name><name><surname>Paiardini</surname><given-names>A.</given-names></name><name><surname>Hoogewijs</surname><given-names>D.</given-names></name><name><surname>Forte</surname><given-names>E.</given-names></name><name><surname>Giuffr&#x000e8;</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Bacterial oxidases of the cytochrome bd Family: redox enzymes of unique structure, function, and utility as drug targets</article-title><source>Antioxid. Redox Signal.</source><volume>34</volume><year>2021</year><fpage>1280</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">32924537</pub-id>
</element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>E.J.R.</given-names></name><name><surname>Abidi</surname><given-names>A.A.</given-names></name><name><surname>Arrieta-Ortiz</surname><given-names>M.L.</given-names></name><name><surname>Aguilar</surname><given-names>B.</given-names></name><name><surname>Yurkovich</surname><given-names>J.T.</given-names></name><name><surname>Kaur</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Intricate genetic programs controlling dormancy in Mycobacterium tuberculosis</article-title><source>Cell Rep.</source><volume>31</volume><year>2020</year><object-id pub-id-type="publisher-id">107577</object-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Sohaskey</surname><given-names>C.D.</given-names></name><name><surname>Kana</surname><given-names>B.D.</given-names></name><name><surname>Dawes</surname><given-names>S.</given-names></name><name><surname>North</surname><given-names>R.J.</given-names></name><name><surname>Mizrahi</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in&#x000a0;vitro conditions affecting aerobic respiration</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>102</volume><year>2005</year><fpage>15629</fpage><lpage>15634</lpage><pub-id pub-id-type="pmid">16227431</pub-id>
</element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.P.</given-names></name><name><surname>Hasenoehrl</surname><given-names>E.J.</given-names></name><name><surname>Rahman</surname><given-names>N.B.A.</given-names></name><name><surname>Koh</surname><given-names>V.H.</given-names></name><name><surname>Ang</surname><given-names>M.L.T.</given-names></name><name><surname>Sajorda</surname><given-names>D.R.</given-names></name><etal/></person-group><article-title>Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>114</volume><year>2017</year><fpage>7426</fpage><lpage>7431</lpage><pub-id pub-id-type="pmid">28652330</pub-id>
</element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B.S.</given-names></name><name><surname>Hards</surname><given-names>K.</given-names></name><name><surname>Engelhart</surname><given-names>C.A.</given-names></name><name><surname>Hasenoehrl</surname><given-names>E.J.</given-names></name><name><surname>Kalia</surname><given-names>N.P.</given-names></name><name><surname>Mackenzie</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis</article-title><source>EMBO Mol. Med.</source><volume>13</volume><year>2020</year><object-id pub-id-type="publisher-id">e13207</object-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Giuffr&#x000e8;</surname><given-names>A.</given-names></name><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Arese</surname><given-names>M.</given-names></name><name><surname>Sarti</surname><given-names>P.</given-names></name><name><surname>Forte</surname><given-names>E.</given-names></name></person-group><article-title>Cytochrome bd oxidase and bacterial tolerance to oxidative and nitrosative stress</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1837</volume><year>2014</year><fpage>1178</fpage><lpage>1187</lpage></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Forte</surname><given-names>E.</given-names></name><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Falabella</surname><given-names>M.</given-names></name><name><surname>Cola&#x000e7;o</surname><given-names>H.G.</given-names></name><name><surname>Tinajero-Trejo</surname><given-names>M.</given-names></name><name><surname>Poole</surname><given-names>R.K.</given-names></name><etal/></person-group><article-title>The terminal oxidase cytochrome bd promotes sulfide-resistant bacterial respiration and growth</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><object-id pub-id-type="publisher-id">23788</object-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>P.</given-names></name><name><surname>Heineke</surname><given-names>M.H.</given-names></name><name><surname>Koul</surname><given-names>A.</given-names></name><name><surname>Andries</surname><given-names>K.</given-names></name><name><surname>Cook</surname><given-names>G.M.</given-names></name><name><surname>Lill</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress</article-title><source>Sci. Rep.</source><volume>5</volume><year>2015</year><fpage>10333</fpage><pub-id pub-id-type="pmid">26015371</pub-id>
</element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Beebout</surname><given-names>C.J.</given-names></name><name><surname>Sominsky</surname><given-names>L.A.</given-names></name><name><surname>Eberly</surname><given-names>A.R.</given-names></name><name><surname>Van Horn</surname><given-names>G.T.</given-names></name><name><surname>Hadjifrangiskou</surname><given-names>M.</given-names></name></person-group><article-title>Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals</article-title><source>NPJ Biofilms Microbiomes</source><volume>7</volume><year>2021</year><fpage>35</fpage><pub-id pub-id-type="pmid">33863914</pub-id>
</element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Seregina</surname><given-names>T.A.</given-names></name><name><surname>Lobanov</surname><given-names>K.V.</given-names></name><name><surname>Shakulov</surname><given-names>R.S.</given-names></name><name><surname>Mironov</surname><given-names>A.S.</given-names></name></person-group><article-title>Inactivation of terminal oxidase bd-I leads to supersensitivity of E. coli to quinolone and beta-lactam antibiotics</article-title><source>Mol. Biol.</source><volume>56</volume><year>2022</year><fpage>572</fpage><lpage>579</lpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group><article-title>The cytochrome bd complex is essential for chromate and sulfide resistance and is regulated by a GbsR-type regulator, CydE, in Alishewanella Sp. WH16-1</article-title><source>Front. Microbiol.</source><volume>9</volume><year>2018</year><fpage>1849</fpage><pub-id pub-id-type="pmid">30147685</pub-id>
</element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Safarian</surname><given-names>S.</given-names></name><name><surname>Opel-Reading</surname><given-names>H.K.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Mehdipour</surname><given-names>A.R.</given-names></name><name><surname>Hards</surname><given-names>K.</given-names></name><name><surname>Harold</surname><given-names>L.K.</given-names></name><etal/></person-group><article-title>The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>5236</fpage><pub-id pub-id-type="pmid">34475399</pub-id>
</element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Grund</surname><given-names>T.N.</given-names></name><name><surname>Kabashima</surname><given-names>Y.</given-names></name><name><surname>Kusumoto</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Welsch</surname><given-names>S.</given-names></name><name><surname>Sakamoto</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The cryoEM structure of cytochrome bd from C. glutamicum provides novel insights into structural properties of actinobacterial terminal oxidases</article-title><source>Front. Chem.</source><volume>10</volume><year>2023</year><object-id pub-id-type="publisher-id">1085463</object-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Safarian</surname><given-names>S.</given-names></name><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Mills</surname><given-names>D.J.</given-names></name><name><surname>Radloff</surname><given-names>M.</given-names></name><name><surname>Eisinger</surname><given-names>M.L.</given-names></name><name><surname>Nikolaev</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Active site rearrangement and structural divergence in prokaryotic respiratory oxidases</article-title><source>Science</source><volume>366</volume><year>2019</year><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">31604309</pub-id>
</element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Mogi</surname><given-names>T.</given-names></name><name><surname>Akimoto</surname><given-names>S.</given-names></name><name><surname>Endou</surname><given-names>S.</given-names></name><name><surname>Watanabe-Nakayama</surname><given-names>T.</given-names></name><name><surname>Mizuochi-Asai</surname><given-names>E.</given-names></name><name><surname>Miyoshi</surname><given-names>H.</given-names></name></person-group><article-title>Probing the ubiquinol-binding site in cytochrome bd by site-directed mutagenesis</article-title><source>Biochemistry</source><volume>45</volume><year>2006</year><fpage>7924</fpage><lpage>7930</lpage><pub-id pub-id-type="pmid">16784245</pub-id>
</element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Grund</surname><given-names>T.N.</given-names></name><name><surname>Radloff</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Goojani</surname><given-names>H.G.</given-names></name><name><surname>Witte</surname><given-names>L.F.</given-names></name><name><surname>J&#x000f6;sting</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Mechanistic and structural diversity between cytochrome bd isoforms of Escherichia coli</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>118</volume><year>2021</year><object-id pub-id-type="publisher-id">e2114013118</object-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Harikishore</surname><given-names>A.</given-names></name><name><surname>Mathiyazakan</surname><given-names>V.</given-names></name><name><surname>Pethe</surname><given-names>K.</given-names></name><name><surname>Gr&#x000fc;ber</surname><given-names>G.</given-names></name></person-group><article-title>Novel targets and inhibitors of the Mycobacterium tuberculosis cytochrome bd oxidase to foster anti-tuberculosis drug discovery</article-title><source>Expert Opin. Drug Discov.</source><volume>18</volume><year>2023</year><fpage>917</fpage><lpage>927</lpage><pub-id pub-id-type="pmid">37332221</pub-id>
</element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Lamprecht</surname><given-names>D.A.</given-names></name><name><surname>Finin</surname><given-names>P.M.</given-names></name><name><surname>Rahman</surname><given-names>M.A.</given-names></name><name><surname>Cumming</surname><given-names>B.M.</given-names></name><name><surname>Russell</surname><given-names>S.L.</given-names></name><name><surname>Jonnala</surname><given-names>S.R.</given-names></name><etal/></person-group><article-title>Turning the respiratory flexibility of Mycobacterium tuberculosis against itself</article-title><source>Nat. Commun.</source><volume>7</volume><year>2016</year><object-id pub-id-type="publisher-id">12393</object-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.P.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Hards</surname><given-names>K.</given-names></name><name><surname>Cheung</surname><given-names>C.Y.</given-names></name><name><surname>Sviriaeva</surname><given-names>E.</given-names></name><name><surname>Banaei-Esfahani</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environments</article-title><source>Cell Rep.</source><volume>42</volume><year>2023</year><object-id pub-id-type="publisher-id">112444</object-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Cremers</surname><given-names>C.M.</given-names></name><name><surname>Jakob</surname><given-names>U.</given-names></name></person-group><article-title>Oxidant sensing by reversible disulfide bond formation</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>288</volume><year>2013</year><fpage>26489</fpage><lpage>26496</lpage><pub-id pub-id-type="pmid">23861395</pub-id>
</element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A.R.</given-names></name><name><surname>Mota</surname><given-names>C.</given-names></name><name><surname>Vilela-Alves</surname><given-names>G.</given-names></name><name><surname>Manuel</surname><given-names>R.R.</given-names></name><name><surname>Pedrosa</surname><given-names>N.</given-names></name><name><surname>Fourmond</surname><given-names>V.</given-names></name><etal/></person-group><article-title>An allosteric redox switch involved in oxygen protection in a CO2 reductase</article-title><source>Nat. Chem. Biol.</source><volume>20</volume><year>2023</year><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">37985883</pub-id>
</element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Unden</surname><given-names>G.</given-names></name><name><surname>Bongaerts</surname><given-names>J.</given-names></name></person-group><article-title>Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors</article-title><source>Biochim. Biophys. Acta</source><volume>1320</volume><year>1997</year><fpage>217</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">9230919</pub-id>
</element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Kaurola</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Vonk</surname><given-names>A.</given-names></name><name><surname>Vattulainen</surname><given-names>I.</given-names></name><name><surname>R&#x000f3;g</surname><given-names>T.</given-names></name></person-group><article-title>Distribution and dynamics of quinones in the lipid bilayer mimicking the inner membrane of mitochondria</article-title><source>Biochim. Biophys. Acta Biomembr.</source><volume>1858</volume><year>2016</year><fpage>2116</fpage><lpage>2122</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>M.D.</given-names></name><name><surname>Jones</surname><given-names>D.</given-names></name></person-group><article-title>Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implications</article-title><source>Microbiol. Rev.</source><volume>45</volume><year>1981</year><fpage>316</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">7022156</pub-id>
</element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Teixeira De Mattos</surname><given-names>M.J.</given-names></name><name><surname>Hellingwerf</surname><given-names>K.J.</given-names></name><name><surname>Bekker</surname><given-names>M.</given-names></name></person-group><article-title>On the function of the various quinone species in Escherichia coli</article-title><source>FEBS J.</source><volume>279</volume><year>2012</year><fpage>3364</fpage><lpage>3373</lpage><pub-id pub-id-type="pmid">22521170</pub-id>
</element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>van Beilen</surname><given-names>J.W.A.</given-names></name><name><surname>Hellingwerf</surname><given-names>K.J.</given-names></name></person-group><article-title>All three endogenous quinone species of Escherichia coli are involved in controlling the activity of the aerobic/anaerobic response regulator ArcA</article-title><source>Front. Microbiol.</source><volume>7</volume><year>2016</year><fpage>1339</fpage><pub-id pub-id-type="pmid">27656164</pub-id>
</element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Gennis</surname><given-names>R.B.</given-names></name><name><surname>Hemp</surname><given-names>J.</given-names></name><name><surname>Verkhovsky</surname><given-names>M.I.</given-names></name></person-group><article-title>The cytochrome bd respiratory oxygen reductases</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1807</volume><year>2011</year><fpage>1398</fpage><lpage>1413</lpage></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Lorence</surname><given-names>R.M.</given-names></name><name><surname>Miller</surname><given-names>M.J.</given-names></name><name><surname>Borochov</surname><given-names>A.</given-names></name><name><surname>Faiman-Weinberg</surname><given-names>R.</given-names></name><name><surname>Gennis</surname><given-names>R.B.</given-names></name></person-group><article-title>Effects of pH and detergent on the kinetic and electrochemical properties of the purified cytochrome d terminal oxidase complex of <italic>Escherichia coli</italic></article-title><source>Biochim. Biophys. Acta</source><volume>790</volume><year>1984</year><fpage>148</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">6386051</pub-id>
</element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Asseri</surname><given-names>A.H.</given-names></name><name><surname>Godoy-Hernandez</surname><given-names>A.</given-names></name><name><surname>Goojani</surname><given-names>H.G.</given-names></name><name><surname>Lill</surname><given-names>H.</given-names></name><name><surname>Sakamoto</surname><given-names>J.</given-names></name><name><surname>McMillan</surname><given-names>D.G.G.</given-names></name><etal/></person-group><article-title>Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo 3 solubilized in dodecyl-maltoside</article-title><source>Sci. Rep.</source><volume>11</volume><year>2021</year><fpage>8006</fpage><pub-id pub-id-type="pmid">33850195</pub-id>
</element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Fontes</surname><given-names>F.L.</given-names></name><name><surname>Gonzalez-Juarrero</surname><given-names>M.</given-names></name><name><surname>McNeil</surname><given-names>M.R.</given-names></name><name><surname>Crans</surname><given-names>D.C.</given-names></name><name><surname>Jackson</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Partial saturation of menaquinone in mycobacterium tuberculosis: function and essentiality of a novel reductase, MenJ</article-title><source>ACS Cent. Sci.</source><volume>1</volume><year>2015</year><fpage>292</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">26436137</pub-id>
</element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Biner</surname><given-names>O.</given-names></name><name><surname>Fedor</surname><given-names>J.G.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Hirst</surname><given-names>J.</given-names></name></person-group><article-title>Bottom-up construction of a minimal system for cellular respiration and energy regeneration</article-title><source>ACS Synth. Biol.</source><volume>9</volume><year>2020</year><fpage>1450</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">32383867</pub-id>
</element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Yanofsky</surname><given-names>D.J.</given-names></name><name><surname>Di Trani</surname><given-names>J.M.</given-names></name><name><surname>Krol</surname><given-names>S.</given-names></name><name><surname>Abdelaziz</surname><given-names>R.</given-names></name><name><surname>Bueler</surname><given-names>S.A.</given-names></name><name><surname>Imming</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Structure of mycobacterial CIII2CIV2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203)</article-title><source>Elife</source><volume>10</volume><year>2021</year><object-id pub-id-type="publisher-id">e71959</object-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Muneyuki</surname><given-names>E.</given-names></name><name><surname>Fujita</surname><given-names>D.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Miyoshi</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Kinetic mechanism of quinol oxidation by cytochrome bd studied with ubiquinone-2 analogs</article-title><source>J.&#x000a0;Biochem.</source><volume>139</volume><year>2006</year><fpage>779</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">16672279</pub-id>
</element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Miyoshi</surname><given-names>H.</given-names></name><name><surname>Takegami</surname><given-names>K.</given-names></name><name><surname>Mogi</surname><given-names>T.</given-names></name><name><surname>Anraku</surname><given-names>Y.</given-names></name><name><surname>Iwamura</surname><given-names>H.</given-names></name></person-group><article-title>Probing substrate binding site of the Escherichia coli quinol oxidases using synthetic ubiquinol analogues</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>271</volume><year>1996</year><fpage>29897</fpage><lpage>29902</lpage><pub-id pub-id-type="pmid">8939932</pub-id>
</element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Sviriaeva</surname><given-names>E.</given-names></name><name><surname>Subramanian Manimekalai</surname><given-names>M.S.</given-names></name><name><surname>Gr&#x000fc;ber</surname><given-names>G.</given-names></name><name><surname>Pethe</surname><given-names>K.</given-names></name></person-group><article-title>Features and functional importance of key residues of the Mycobacterium tuberculosis cytochrome bd oxidase</article-title><source>ACS Infect. Dis.</source><volume>6</volume><year>2020</year><fpage>1697</fpage><lpage>1707</lpage><pub-id pub-id-type="pmid">32379966</pub-id>
</element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Lai</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Cryo-EM structure of mycobacterial cytochrome bd reveals two oxygen access channels</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>4621</fpage><pub-id pub-id-type="pmid">34330928</pub-id>
</element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Radloff</surname><given-names>M.</given-names></name><name><surname>Elamri</surname><given-names>I.</given-names></name><name><surname>Grund</surname><given-names>T.N.</given-names></name><name><surname>Witte</surname><given-names>L.F.</given-names></name><name><surname>Hohmann</surname><given-names>K.F.</given-names></name><name><surname>Nakagaki</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Short-chain aurachin D derivatives are selective inhibitors of E. coli cytochrome bd-I and bd-II oxidases</article-title><source>Sci. Rep.</source><volume>11</volume><year>2021</year><object-id pub-id-type="publisher-id">23852</object-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>K.</given-names></name><name><surname>Konishi</surname><given-names>K.</given-names></name><name><surname>Anraku</surname><given-names>Y.</given-names></name></person-group><article-title>Terminal oxidases of Escherichia coli aerobic respiratory chain. II. Purification and properties of cytochrome b558-d complex from cells grown with limited oxygen and evidence of branched electron-carrying systems</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>259</volume><year>1984</year><fpage>3375</fpage><lpage>3381</lpage><pub-id pub-id-type="pmid">6321507</pub-id>
</element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M.J.</given-names></name><name><surname>Gennis</surname><given-names>R.B.</given-names></name></person-group><article-title>The purification and characterization of the cytochrome d terminal oxidase complex of the Escherichia coli aerobic respiratory chain</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>258</volume><year>1983</year><fpage>9159</fpage><lpage>9165</lpage><pub-id pub-id-type="pmid">6307994</pub-id>
</element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Shestopalov</surname><given-names>A.I.</given-names></name><name><surname>Bogachev</surname><given-names>A.V.</given-names></name><name><surname>Murtazina</surname><given-names>R.A.</given-names></name><name><surname>Viryasov</surname><given-names>M.B.</given-names></name><name><surname>Skulachev</surname><given-names>V.P.</given-names></name></person-group><article-title>Aeration-dependent changes in composition of the quinone pool in Escherichia coli</article-title><source>FEBS Lett.</source><volume>404</volume><year>1997</year><fpage>272</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">9119077</pub-id>
</element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Kusumoto</surname><given-names>K.</given-names></name><name><surname>Sakiyama</surname><given-names>M.</given-names></name><name><surname>Sakamoto</surname><given-names>J.</given-names></name><name><surname>Noguchi</surname><given-names>S.</given-names></name><name><surname>Sone</surname><given-names>N.</given-names></name></person-group><article-title>Menaquinol oxidase activity and primary structure of cytochrome bd from the amino-acid fermenting bacterium Corynebacterium glutamicum</article-title><source>Arch. Microbiol.</source><volume>173</volume><year>2000</year><fpage>390</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">10896219</pub-id>
</element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Jeffreys</surname><given-names>L.N.</given-names></name><name><surname>Ardrey</surname><given-names>A.</given-names></name><name><surname>Hafiz</surname><given-names>T.A.</given-names></name><name><surname>Dyer</surname><given-names>L.A.</given-names></name><name><surname>Warman</surname><given-names>A.J.</given-names></name><name><surname>Mosallam</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Identification of 2-aryl-quinolone inhibitors of cytochrome bd and chemical validation of combination strategies for respiratory inhibitors against Mycobacterium tuberculosis</article-title><source>ACS Infect. Dis.</source><volume>9</volume><year>2023</year><fpage>221</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">36606559</pub-id>
</element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Vallese</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>S.K.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Cryo-EM structures of Escherichia coli cytochrome bo3 reveal bound phospholipids and ubiquinone-8 in a dynamic substrate binding site</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>118</volume><year>2021</year><object-id pub-id-type="publisher-id">e2106750118</object-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>Y.</given-names></name><name><surname>Shimaki</surname><given-names>Y.</given-names></name><name><surname>Dutta</surname><given-names>D.</given-names></name><name><surname>Muench</surname><given-names>S.P.</given-names></name><name><surname>Ireton</surname><given-names>K.</given-names></name><name><surname>Cook</surname><given-names>G.M.</given-names></name><etal/></person-group><article-title>Unprecedented properties of phenothiazines unraveled by a NDH-2 bioelectrochemical assay platform</article-title><source>J.&#x000a0;Am. Chem. Soc.</source><volume>142</volume><year>2020</year><fpage>1311</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">31880924</pub-id>
</element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Nikolaev</surname><given-names>A.</given-names></name><name><surname>Safarian</surname><given-names>S.</given-names></name><name><surname>Thesseling</surname><given-names>A.</given-names></name><name><surname>Wohlwend</surname><given-names>D.</given-names></name><name><surname>Friedrich</surname><given-names>T.</given-names></name><name><surname>Michel</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Electrocatalytic evidence of the diversity of the oxygen reaction in the bacterial bd oxidase from different organisms</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1862</volume><year>2021</year><object-id pub-id-type="publisher-id">148436</object-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>W.C.</given-names></name><name><surname>Kleinschroth</surname><given-names>T.</given-names></name><name><surname>Nitschke</surname><given-names>W.</given-names></name><name><surname>Baymann</surname><given-names>F.</given-names></name><name><surname>Neehaul</surname><given-names>Y.</given-names></name><name><surname>Hellwig</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The obligate respiratory supercomplex from Actinobacteria</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1857</volume><year>2016</year><fpage>1705</fpage><lpage>1714</lpage></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Sukheja</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Mittal</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>S.G.</given-names></name><name><surname>Singleton</surname><given-names>E.</given-names></name><name><surname>Russo</surname><given-names>R.</given-names></name><etal/></person-group><article-title>A novel small-molecule inhibitor of the mycobacterium tuberculosis demethylmenaquinone methyltransferase meng is bactericidal to both growing and nutritionally deprived persister cells</article-title><source>mBio</source><volume>8</volume><year>2017</year><object-id pub-id-type="publisher-id">e02022-16</object-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Velappan</surname><given-names>A.B.</given-names></name><name><surname>Datta</surname><given-names>D.</given-names></name><name><surname>Ma</surname><given-names>R.</given-names></name><name><surname>Rana</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>K.S.</given-names></name><name><surname>Hari</surname><given-names>N.</given-names></name><etal/></person-group><article-title>2-Aryl benzazole derived new class of anti-tubercular compounds: endowed to eradicate mycobacterium tuberculosis in replicating and non-replicating forms</article-title><source>Bioorg. Chem.</source><volume>103</volume><year>2020</year><object-id pub-id-type="publisher-id">104170</object-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Farhana</surname><given-names>A.</given-names></name><name><surname>Guidry</surname><given-names>L.</given-names></name><name><surname>Saini</surname><given-names>V.</given-names></name><name><surname>Hondalus</surname><given-names>M.</given-names></name><name><surname>Steyn</surname><given-names>A.J.C.</given-names></name></person-group><article-title>Redox homeostasis in mycobacteria: the key to tuberculosis control?</article-title><source>Expert Rev. Mol. Med.</source><volume>13</volume><year>2011</year><fpage>e39</fpage><pub-id pub-id-type="pmid">22172201</pub-id>
</element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>V.</given-names></name><name><surname>Cumming</surname><given-names>B.M.</given-names></name><name><surname>Guidry</surname><given-names>L.</given-names></name><name><surname>Lamprecht</surname><given-names>D.A.</given-names></name><name><surname>Adamson</surname><given-names>J.H.</given-names></name><name><surname>Reddy</surname><given-names>V.P.</given-names></name><etal/></person-group><article-title>Ergothioneine maintains redox and bioenergetic homeostasis essential for drug susceptibility and virulence of Mycobacterium tuberculosis</article-title><source>Cell Rep.</source><volume>14</volume><year>2016</year><fpage>572</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">26774486</pub-id>
</element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Voskuil</surname><given-names>M.I.</given-names></name><name><surname>Bartek</surname><given-names>I.L.</given-names></name><name><surname>Visconti</surname><given-names>K.</given-names></name><name><surname>Schoolnik</surname><given-names>G.K.</given-names></name></person-group><article-title>The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species</article-title><source>Front. Microbiol.</source><volume>2</volume><year>2011</year><fpage>105</fpage><pub-id pub-id-type="pmid">21734908</pub-id>
</element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Tur</surname><given-names>J.</given-names></name><name><surname>Pereira-Lopes</surname><given-names>S.</given-names></name><name><surname>Vico</surname><given-names>T.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>E.A.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>J.P.</given-names></name><name><surname>Hern&#x000e1;ndez-Alvarez</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Mitofusin 2 in macrophages links mitochondrial ROS production, cytokine release, phagocytosis, autophagy, and bactericidal activity</article-title><source>Cell Rep</source><volume>32</volume><year>2020</year><object-id pub-id-type="publisher-id">108079</object-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Small</surname><given-names>J.L.</given-names></name><name><surname>Park</surname><given-names>S.W.</given-names></name><name><surname>Kana</surname><given-names>B.D.</given-names></name><name><surname>Ioerger</surname><given-names>T.R.</given-names></name><name><surname>Sacchettini</surname><given-names>J.C.</given-names></name><name><surname>Ehrt</surname><given-names>S.</given-names></name></person-group><article-title>Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in Mycobacterium tuberculosis</article-title><source>mBio</source><volume>4</volume><year>2013</year><fpage>475</fpage><lpage>488</lpage></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Al-Attar</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Pinkse</surname><given-names>M.</given-names></name><name><surname>Hoeser</surname><given-names>J.</given-names></name><name><surname>Friedrich</surname><given-names>T.</given-names></name><name><surname>Bald</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Cytochrome <italic>bd</italic> displays significant quinol peroxidase activity</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><object-id pub-id-type="publisher-id">27631</object-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Borisov</surname><given-names>V.B.</given-names></name><name><surname>Forte</surname><given-names>E.</given-names></name><name><surname>Siletsky</surname><given-names>S.A.</given-names></name><name><surname>Sarti</surname><given-names>P.</given-names></name><name><surname>Giuffr&#x000e8;</surname><given-names>A.</given-names></name></person-group><article-title>Cytochrome bd from Escherichia coli catalyzes peroxynitrite decomposition</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1847</volume><year>2015</year><fpage>182</fpage><lpage>188</lpage></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Goojani</surname><given-names>H.G.</given-names></name><name><surname>Konings</surname><given-names>J.</given-names></name><name><surname>Hakvoort</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Gennis</surname><given-names>R.B.</given-names></name><name><surname>Sakamoto</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The carboxy-terminal insert in the Q-loop is needed for functionality of Escherichia coli cytochrome bd-I</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><volume>1861</volume><year>2020</year><object-id pub-id-type="publisher-id">148175</object-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Bekker</surname><given-names>M.</given-names></name><name><surname>De Vries</surname><given-names>S.</given-names></name><name><surname>Ter Beek</surname><given-names>A.</given-names></name><name><surname>Hellingwerf</surname><given-names>K.J.</given-names></name><name><surname>Teixeira De Mattos</surname><given-names>M.J.</given-names></name></person-group><article-title>Respiration of Escherichia coli can be fully uncoupled <italic>via</italic> the nonelectrogenic terminal cytochrome bd-II oxidase</article-title><source>J.&#x000a0;Bacteriol.</source><volume>191</volume><year>2009</year><fpage>5510</fpage><lpage>5517</lpage><pub-id pub-id-type="pmid">19542282</pub-id>
</element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>H.</given-names></name><name><surname>Kawakami</surname><given-names>T.</given-names></name><name><surname>Osamura</surname><given-names>T.</given-names></name><name><surname>Hirai</surname><given-names>T.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Ishii</surname><given-names>M.</given-names></name></person-group><article-title>Enzymatic characterization and <italic>in&#x000a0;vivo</italic> function of five terminal oxidases in Pseudomonas aeruginosa</article-title><source>J.&#x000a0;Bacteriol.</source><volume>196</volume><year>2014</year><fpage>4206</fpage><lpage>4215</lpage><pub-id pub-id-type="pmid">25182500</pub-id>
</element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Williams</surname><given-names>Z.</given-names></name><name><surname>Hards</surname><given-names>K.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Cheung</surname><given-names>C.Y.</given-names></name><name><surname>Aung</surname><given-names>H.L.</given-names></name><etal/></person-group><article-title>Pyrazolo[1,5- a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis</article-title><source>ACS Infect. Dis.</source><volume>5</volume><year>2019</year><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">30485737</pub-id>
</element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Heikal</surname><given-names>A.</given-names></name><name><surname>Nakatani</surname><given-names>Y.</given-names></name><name><surname>Dunn</surname><given-names>E.</given-names></name><name><surname>Weimar</surname><given-names>M.R.</given-names></name><name><surname>Day</surname><given-names>C.L.</given-names></name><name><surname>Baker</surname><given-names>E.N.</given-names></name><etal/></person-group><article-title>Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation</article-title><source>Mol. Microbiol.</source><volume>91</volume><year>2014</year><fpage>950</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">24444429</pub-id>
</element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Godoy-Hernandez</surname><given-names>A.</given-names></name><name><surname>Asseri</surname><given-names>A.H.</given-names></name><name><surname>Purugganan</surname><given-names>A.J.</given-names></name><name><surname>Jiko</surname><given-names>C.</given-names></name><name><surname>de Ram</surname><given-names>C.</given-names></name><name><surname>Lill</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Rapid and highly stable membrane reconstitution by LAiR enables the study of physiological integral membrane protein functions</article-title><source>ACS Cent. Sci.</source><volume>9</volume><year>2023</year><fpage>494</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">36968527</pub-id>
</element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Tsubaki</surname><given-names>M.</given-names></name><name><surname>Hori</surname><given-names>H.</given-names></name><name><surname>Mogi</surname><given-names>T.</given-names></name><name><surname>Anraku</surname><given-names>Y.</given-names></name></person-group><article-title>Cyanide-binding site of bd-type ubiquinol oxidase from Escherichia coli</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>270</volume><year>1995</year><fpage>28565</fpage><lpage>28569</lpage><pub-id pub-id-type="pmid">7499371</pub-id>
</element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Punjani</surname><given-names>A.</given-names></name><name><surname>Rubinstein</surname><given-names>J.L.</given-names></name><name><surname>Fleet</surname><given-names>D.J.</given-names></name><name><surname>Brubaker</surname><given-names>M.A.</given-names></name></person-group><article-title>CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</article-title><source>Nat. Methods</source><volume>14</volume><year>2017</year><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">28165473</pub-id>
</element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Punjani</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Fleet</surname><given-names>D.J.</given-names></name></person-group><article-title>Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction</article-title><source>Nat. Methods</source><volume>17</volume><year>2020</year><fpage>1214</fpage><lpage>1221</lpage><pub-id pub-id-type="pmid">33257830</pub-id>
</element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="opthc4Md2j9mT"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P.</given-names></name><name><surname>Lohkamp</surname><given-names>B.</given-names></name><name><surname>Scott</surname><given-names>W.G.</given-names></name><name><surname>Cowtan</surname><given-names>K.</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>66</volume><year>2010</year><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">20383002</pub-id>
</element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="optMid7AKLCXz"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>E.F.</given-names></name><name><surname>Goddard</surname><given-names>T.D.</given-names></name><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Meng</surname><given-names>E.C.</given-names></name><name><surname>Couch</surname><given-names>G.S.</given-names></name><name><surname>Croll</surname><given-names>T.I.</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: structure visualization for researchers, educators, and developers</article-title><source>Protein Sci.</source><volume>30</volume><year>2021</year><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">32881101</pub-id>
</element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="optLABmS5FGWX"><person-group person-group-type="author"><name><surname>Sajed</surname><given-names>T.</given-names></name><name><surname>Marcu</surname><given-names>A.</given-names></name><name><surname>Ramirez</surname><given-names>M.</given-names></name><name><surname>Pon</surname><given-names>A.</given-names></name><name><surname>Guo</surname><given-names>A.C.</given-names></name><name><surname>Knox</surname><given-names>C.</given-names></name><etal/></person-group><article-title>ECMDB 2.0: A richer resource for understanding the biochemistry of <italic>E. coli</italic></article-title><source>Nucleic Acids Res.</source><volume>44</volume><year>2016</year><fpage>D495</fpage><lpage>D501</lpage><pub-id pub-id-type="pmid">26481353</pub-id>
</element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>T.D.</given-names></name><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Meng</surname><given-names>E.C.</given-names></name><name><surname>Pettersen</surname><given-names>E.F.</given-names></name><name><surname>Couch</surname><given-names>G.S.</given-names></name><name><surname>Morris</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: meeting modern challenges in visualization and analysis</article-title><source>Protein Sci.</source><volume>27</volume><year>2018</year><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">28710774</pub-id>
</element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supporting information</title><p id="p0265">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Supporting information</title></caption><media xlink:href="mmc1.docx"/></supplementary-material>
</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0255">We thank Dr Dirk Bald (VU Amsterdam, The Netherlands) for providing the MB43&#x000a0;cells and the pET17b_CydABX_Linkerstreptag construct for <italic>Ecbd</italic> expression. Furthermore, we thank Prof Dr Gregory Cook (University of Otago, New Zealand) for providing the MC<sup>2</sup> 155 &#x00394;CydAB strain and pLHCyd plasmid for <italic>Mtbd</italic> expression. This work benefited from access to the Netherlands Centre for Electron Nanoscopy (NeCEN) and the ALICE compute resources provided by Leiden University.</p><sec id="sec7"><title>Author contributions</title><p id="p0260">L. J. conceptualization; S. B., K. K., T. T. v. d. V., and L. J. methodology; K. K. and T. T. v. d. V. formal analysis; C. W. and T. T. v. d. V. investigation; T. T. v. d. V. writing&#x02013;original draft; S. B., K. K., and L. J. writing&#x02013;review &#x00026; editing; T. T. v. d. V. visualization; S. B. and L. J. supervision; L. J. project administration.</p></sec></ack></back></article>